PHYTOCANNABINOIDS (2010-2015)

+ PHYTOCANNABINOIDS & RELATED COMPOUNDS 2000–2009

PHYTOCANNABINOIDS News Articles 2010-2016

PHYTOCANNABINOIDS & RELATED COMPOUNDS 2010–2015


AMYRINS (Phytochemicals that Inhibit the Breakdown of 2-AG)
ANTHOCYANINS/ANTHOCYADINS (Plant Pigments, Moderately Activate CB1 and CB2 Receptors)
BETA-CARYOPHYLLENE/(E)-BCP + (CB2 Agonist, See Also TRANS-CARYOPHYLLENE)
CANNABINOIDS IN OTHER PLANTS (See Also MAGNOLOL, CHOCOLATE, ECHINACEA, TEA)
CANNADOR (Cannabis Extract in Pill Form)
CANNFLAVIN-A/CANNFLAVIN-B (Non-Cannabinoid Compounds from Cannabis)
CBC/CANNABICHROMENE + (Phytocannabinoid, Unknown Receptor)
CBD/CANNABIDIOL/GWP-42003 + (Agonist of the 5-HT1A Receptor, Antagonist of CB1 and CB2, GPR–55 and GPR-18)
CBDA/CANNABIDIOLIC ACID + (Precursor to Cannabidiol)
CBDV/CANNABIDIVARIN (Unknown Receptor)
CBG/CANNABIGEROL + (CB2 Agonist, Inhibits the Reuptake of Endocannabinoids)
CBGA/CANNABIGEROLIC ACID (Precursor of Cannabigerol)
CBN/CANNABINOL (CB2 Agonist, Weak CB1 Agonist)
C28H34N2O6 (Secondary Metabolite of THC)
CHOCOLATE + (Contains a Tiny Amount of Anandamide and Compounds that Block its Breakdown)
ECHINACEA
ELIXINOL
ENTOURAGE EFFECT–PHYTOCANNABINOIDS
FLAVONOIDS
GW-42004 (See CBD/CANNABIDIOL/GWP-42003)
GWP-42006 (See THCV/TETRAHYDROCANNABIVARIN)
HONKIOL (From Magnolia Trees, CB1 Agonist, CB2 Antagonist, See Also 4’-O-METHYLHONOKIOL, MAGNOLOL)
IDRASIL (Natural, Phytocannabinoid Pill, Available Only in California)
MAGNOLOL (From Magnolia Trees, CB2 Agonist and GPR-55 Antagonist)
MELILOTUS SUAVEOLENS LEDAB/SWEET MELIOT (May Increase the Number of CB2 Receptors)
NAMISOL (THC Tablet)
4’-O-METHYLHONOKIOL (From Magnolia Trees, CB2 Agonist, Increases 2-AG Levels. See Also MAGNOLOL, HONKIOL)
OLIVE OIL (May Cause a Temporary Upregulation of CB1 Tumor Suppressor Gene)
PHYTOCANNABINOIDS/PLANT EXTRACTS +
SATIVEX/NABIXIMOLS (THC/CBD Cannabis Extract Oral Spray, Legal in UK, NZ, Australia but not USA)
TEA (Camellia sinensis L) (Weakly Activates CB1 and CB2 Receptors)
TERPENOIDS/TERPENES + (Help Cannabinoids Work Better, See Also BETA-CARYOPHYLLENE/(E)-BCP)
THC/TETRAHYDROCANNABINOL + (CB1 and CB2 Agonist)
THC ACID/THCA (Non-Psychoactive Precursor of THC)
TETRAHYDROCANNABIORCOL (Activates the TRPA1 Channel like Acetaminophen Does)
THCV/TETRAHYDROCANNABIVARIN/GWP-42004 + (CB1 and CB2 Antagonist)
TRANS-CARYOPHYLLENE (CB2 Agonist)
top


AMYRINS
Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits inflammatory and neuropathic persistent pain in mice (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21620566
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting CB receptors (full-2012)
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02059.x/pdf
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full-2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484111/
Adult mortality and blood feeding behavioral effects of α-amyrin acetate, a novel bioactive compound on in vivo exposed females of Anopheles stephensi Liston (Diptera: Culicidae) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22167372
Amyrin and the endocannabinoid system (news–2012) http://gertschgroup.com/blog/entry/3188293/amyrin-and-the-endocannabinoid-system
Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus to Pentacyclic Triterpenoids (full-2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577688/
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23454360


ANTHOCYANINS/ANTHOCYADINS
What Makes Cannabis Purple? (news-2014) http://sensiseeds.com/en/blog/what-makes-cannabis-purple/


BETA-CARYOPHYLLENE/(E)-BCP
Cannabinoid and Terpenoid Reference Guide (undated) http://steephilllab.com/resources/cannabinoid-and-terpenoid-reference-guide/
Terpenes, Terpenoids and Cannabis (news-2010) http://berkeleypatientscare.com/2010/10/08/terpenes-terpenoids-and-cannabis/
Screening for Antiviral Activities of Isolated Compounds from Essential Oils (full-2011) http://www.hindawi.com/journals/ecam/2011/253643/
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070571/
Terpenoids, ‘minor’ cannabinoids contribute to ‘entourage effect’ of cannabis-based medicines (news–2011) http://www.scribd.com/doc/73090396/Terpenoids-%E2%80%98minor%E2%80%99-cannabinoidscontribute-to-%E2%80%98entourage-effect%E2%80%99-of-cannabis-based-medicines-O-Shaughnessy-sAutumn-2011
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312970/
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart-2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
top
Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23138934
Getting the Flax Straight about Cannabidiol (news–2012)  http://www.examiner.com/article/getting-the-flax-straight-about-cannabidiol
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news-2012) http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
Towards a better Cannabis drug (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full-2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The endocannabinoid system, cannabinoids, and pain (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (full-2013) http://ajp.amjpathol.org/article/S0002-9440%2812%2900890-5/fulltext
β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23353590
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news–2013) http://www.sciencedaily.com/releases/2013/02/130221141140.htm
Beta-Caryophyllene: The Dietary Cannabinoid That Could Make Synthetics Irrelevant (news–2013) http://www.leafscience.com/2013/11/12/beta-caryophyllene-dietary-cannabinoid-make-syntheticsirrelevant/
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
Functionalization of β-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24831513
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24999220
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25171128
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst–2014)
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
Cannabinoid and Terpene Info (chart–2015) http://skunkpharmresearch.com/cannabinoid-info/
top


CANNABINOIDS IN OTHER PLANTS
Phytocannabinoids beyond the Cannabis plant – do they exist? (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
New cannabinoid-like chromane and chromene derivatives from Rhododendron anthopogonoides (full–2011) https://www.jstage.jst.go.jp/article/cpb/59/11/59_11_1409/_pdf
Cannabinomimetic lipid from a marine cyanobacterium (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325759/
Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748600/
The CB(1) Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin (turmeric) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22311129
Effect of Nelumbo nucifera Petal Extracts on Lipase, Adipogenesis, Adipolysis, and Central Receptors of Obesity (full–2013) http://www.hindawi.com/journals/ecam/2013/145925/
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OHTamoxifen (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860589/
Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288291
Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24175626
Effects of chaiyuwendan decoction on endocannabinoids levels in adipose tissue of rats with chronic stress-induced depression (full–2014) http://www.journaltcm.com/modules/Journal/contents/stories/141/16.pdf
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full–2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
Indoloditerpenes from a Marine-Derived Fungal Strain of Dichotomomyces cejpii with Antagonistic Activity at GPR18 and Cannabinoid Receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24471526
Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control osteoporosis in aged male rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25136745
Mooreamide A: A Cannabinomimetic Lipid from the Marine Cyanobacterium Moorea bouillonii (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25204580
Truffles contain endocannabinoid metabolic enzymes and anandamide (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25433633
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemiareperfusion through activating cannabinoid receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559


CANNADOR
Marijuana Helps Ease MS Symptoms, Study Finds (news–2012) http://www.healthline.com/health-blogs/study-roundup/marijuana-multiple-sclerosis-101112
Medical Marajuana: Consortium of Multiple Sclerosis Centers (news–2013) http://www.msviews.org/msviewsandnews4/index.php/2012-05-28-00-15-54/2012-07-04-00-19-28/610-medical-marajuana-consortium-of-multiple-sclerosis-centers
top


CANNFLAVIN-A/CANNFLAVIN-B
Microbial metabolism of cannflavin A and B isolated from Cannabis sativa (abst–2010) http://www.sciencedirect.com/science/article/pii/S0031942210000555
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1336533
Cannabinoid and Terpene Info (chart–2015) http://skunkpharmresearch.com/cannabinoid-info/
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837


CBC/CANNABICHROMENE
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by HighPerformance Liquid Chromatography-Tandem Mass Spectrometry (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967639/
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
The endocannabinoid system and cancer: therapeutic implication (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
CANNABIS SATIVA PLANTS RICH IN CANNABICHROMENE AND ITS ACID, EXTRACTS THEREOF AND METHODS OF OBTAINING EXTRACTS THEREFROM (full–2011) http://www.faqs.org/patents/app/20110098348
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041249/
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
The intersection between cannabis and cancer in the United States (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22019199
Cannabinoids in children (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
Cannabis Science Reports: National Cancer Institute Updates Confirm Successful Cancer Treatments with Medical Cannabis (news-2011) http://www.thefreelibrary.com/Cannabis+Science+Reports%3a+National+Cancer+Institute+Updates+Confirm…-a0252875363
top
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417459/
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news–2012)  http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
5 Marijuana Compounds That Could Help Combat Cancer, Alzheimers, Parkinsons (If Only They Were Legal) (news–2012) http://www.alternet.org/drugs/5-marijuana-compounds-could-help-combat-cancer-alzheimers-parkinsonsif-only-they-were-legal
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
The effect cannabichromene on adult neural stem/progenitor cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23941747
5 Health Benefits Of Cannabichromene (CBC) (news–2013) http://www.leafscience.com/2013/09/21/5-health-benefits-of-cannabichromene-cbc/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF–2014) http://www.mdpi.com/1420-3049/19/11/18781
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Cannabinoid Breakdown (news–2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Cannabis Chemistry 101 (news–2014) http://www.greencultured.co/cannabis-chemistry-101/
Cannabinoid and Terpene Info (chart–2015) http://skunkpharmresearch.com/cannabinoid-info/


CBD/CANNABIDIOL/GWP-42003
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full–2010)
http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823358/?tool=pubmed
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Therapeutical use of the cannabinoids in psychiatry (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819831/?tool=pmcentrez
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
top
Antitumorigenic Effects of Cannabinoids beyond Apoptosis (full-2010) http://jpet.aspetjournals.org/content/332/2/336.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy (full-2010) http://www.natap.org/2010/newsUpdates/marijuana.pdf
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/?tool=pubmed
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation (full–2010) http://www.wjgnet.com/1948-9358/full/v1/i1/12.htm
Regulation of nausea and vomiting by cannabinoids (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01176.x/pdf
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival (full-2010) http://mct.aacrjournals.org/content/9/1/180.full
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis (full-2010) http://www.nature.com/npp/journal/v35/n9/full/npp201058a.html
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by HighPerformance Liquid Chromatography-Tandem Mass Spectrometry (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study (full-2010) http://bjp.rcpsych.org/content/197/4/285.long
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full-2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (full-2010) http://ijnp.oxfordjournals.org/content/13/7/861.long
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (full-2010) http://www.jpsmjournal.com/article/S0885-3924%2809%2900787-8/fulltext
Combination Of Cannabinoids For The Treatment Of Peripheral Neuropathic Pain US 2010/ 0035978 A1 Feb. 11, 2010 (full–2010) http://www.cannabisinternational.org/info/Neuropathic-Pain.pdf
Anti-tumoural effects of cannabinoid combinations – Patent TW201002315 (A) ― 2010-01-16 (full-2010) http://worldwide.espacenet.com/publicationDetails/description?CC=TW&NR=201002315A&KC=A&FT=D&ND=3&date=20100116&DB=EPODOC&locale=en_EP
Medicinal Acidic Cannabinoids US Patent 7807711B2 (full–2010) http://www.cannabisinternational.org/info/Medicinal-Acidic-Cannabinoids.pdf
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke (link to PDF–2010) http://www.mdpi.com/1424-8247/3/7/2197
A randomised, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GW42003 : GW42004 plus GW42003 and GW42004 alone in the treatment of dyslipidaemia in subjects with Type 2 diabetes (research summary–2010) http://www.hra.nhs.uk/news/research-summaries/gwmd1092-gw42003gw42004-together-plus-alone-intype-ii-diabetes/#sthash.FT2P6YcB.dpuf
top
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20457188/abstract/Intra_dorsal_periaqueductal_gray_administration_of_cannabidiol_blocks_panic_like_response_by_activating_5_HT1A_receptors_
Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20668920
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform selective and potent inhibitors of human CYP1 enzymes (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20117100
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20545522
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19914218
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20695034
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20561509
Anticonvulsant effects of GWP42006 in vitro and in vivo in rat (abst-2010) http://www.physoc.org/proceedings/abstract/Proc%20Physiol%20Soc%2019C117
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxicischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/19900555/abstract/The_neuroprotective_effect_of_cannabidiol_in_an_in_vitro_model_of_newborn_hypoxic_ischemic_brain_damage_in_mice_is_mediated_by_CB_2__and_adenosine_receptors_
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report (abst-2010) http://jop.sagepub.com/content/25/1/121
Non-psychoactive cannabis to be unveiled at Annual National Clinical Conference on Cannabis Therapeutics (news-2010) http://www.news-medical.net/news/20100409/Non-psychoactive-cannabis-to-be-unveiled-at-AnnualNational-Clinical-Conference-on-Cannabis-Therapeutics.aspx
Prescription Marijuana Without “Intoxicating” Effect in Research Stage (news-2010) http://www.nbclosangeles.com/news/health/Scientists-Aim-to-Make-Marijuana-Perscription-Drug-108736999.html
Key ingredient staves off marijuana memory loss (news-2010) http://www.nature.com/news/2010/101001/full/news.2010.508.html?s=news_rss
Science: Cannabidiol enhances the anti-cancer effects of THC on human brain cancer cells (news–2010) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=313#3
Pot Compound Mitigates Diabetic Cardiomyopathy (news-2010) http://norml.org/news/2010/12/16/pot-compound-mitigates-diabetic-cardiomyopathy
Cannabinoids inhibit and may prevent neuropathic pain in diabetes (news-2010) http://medigardens.blogspot.com/2010/04/march-2010-cannabinoids-inhibit-and-may.html
top
Lab Notes: Pot Has Benefits for Diabetic Hearts (news-2010) http://www.medpagetoday.com/LabNotes/LabNotes/23853
New Analysis Says Cannabis Breeders Should Grow for Safety As Well As Potency (news–2010) http://www.popsci.com/science/article/2010-01/lack-balance-not-thc-makes-pot-health-risk
Cannabidiol (CBD) as an Anti-Arrhythmic – the Role of the CB1 Receptors (news–2010) http://cannabisclinicians.org/2011/cannabidiol-cbd-as-an-anti-arrhythmic-the-role-of-the-cb1-receptors/
Old Hippie’s Definitive Guide To CBD (news–2010) http://beyondchronic.com/2010/12/old-hippie-definitive-guide-cbd-medical-marijuana/
The potential for clinical use of cannabinoids in treatment of cardiovascular diseases (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5922.2010.00233.x/pdf
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410650/
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimers’ disease (full–2011) http://molpharm.aspetjournals.org/content/early/2011/02/24/mol.111.071290.long
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6 (full–2011) http://dmd.aspetjournals.org/content/39/11/2049.full.pdf+html
A combined preclinical therapy of cannabinoids and temozolomide against glioma (full–2011) http://mct.aacrjournals.org/content/10/1/90.full
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?tool=pmcentrez
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/pdf/nihms278422.pdf
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis (full–2011) http://www.nature.com/cddis/journal/v2/n6/pdf/cddis201152a.pdf
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711002310
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242302/
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed
Prospects for cannabinoid therapies in basal ganglia disorders (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
top
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L) (full–2011) http://www.doiserbia.nb.rs/img/doi/0534-0012/2011/0534-00121103449S.pdf
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096803/
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy (full–2011) http://mct.aacrjournals.org/content/10/7/1161.long
Heterogeneity in the composition of marijuana seized in California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118261/pdf/nihms-271313.pdf
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01461.x/pdf
Cannabidiol, a Non-Psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour via Indirect Agonism of 5-HT(1A) Somatodendritic: Autoreceptors in the Dorsal Raphe Nucleus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423241/
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041249/
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration (full–2011) http://www.clinchem.org/content/57/1/66.long
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives (full–2011) http://jop.sagepub.com/content/26/1/150.full.pdf+html
Cannabidiol, a Non-Psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour via Indirect Agonism of 5-HT(1A) Somatodendritic: Autoreceptors in the Dorsal Raphe Nucleus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423241/
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01742.x/full
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186912/pdf/fnbeh-05-00063.pdf
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711000128
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1 (full–2011) http://www.fasebj.org/content/26/4/1535.long
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280884/
top
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Cannabis with high cannabidiol content is associated with fewer psychotic experiences (full–2011) http://www.schres-journal.com/article/S0920-9964%2811%2900224-6/fulltext
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxiaischemia in newborn pigs (full–2011) http://www.nature.com/pr/journal/v70/n3/pdf/pr2011171a.pdf
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent (full-2011) http://www.medicinalgenomics.com/wp-content/uploads/2013/01/Bergamaschi_2011.pdf
US Patent Application 20110082195 – NEW USE FOR CANNABINOIDS (full–2011) http://www.faqs.org/patents/app/20110082195
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ―2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?C=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA (full-2011) http://www.google.it/patents/WO2010012506A1?cl=en
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21704641/abstract/Identification_of_cytochrome_P450_enzymes_responsible_for_metabolism_of_cannabidiol_by_human_liver_microsomes_
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors (abst–2011) http://heart.bmj.com/content/97/24/e8.9.abstract
The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism Related Genes in Microglial Cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21533611
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors (abst-2011) http://marijuana.researchtoday.net/archive/8/1/3517.htm
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243485
Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21667074
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310467
Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21262236
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21867717
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21975813/abstract/The_effects_of_cannabidiolic_acid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_
top
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation (abst-2011) http://www.abstractsonline.com/plan/ViewAbstract.aspx?sKey=94b35de1-74b2-4d46-b062-7c104b5df681&cKey=eca34a2d-da44-4938-b0fa-3a6e652a1756
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessivecompulsive behaviour (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21796370
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21458498
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21798112
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’ (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=315
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21930120
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21915768
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21870037
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21062637/abstract/The_interplay_of_cannabinoid_and_NMDA_glutamate_receptor_systems_in_humans:_preliminary_evidence_of_interactive_effects_of_cannabidiol_and_ketamine_in_healthy_human_subjects_
Cannabidiol induced a contrasting pro-apoptotic effect between freshly isolated and precultured human monocytes (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20471992/abstract/Cannabidiol_induced_a_contrasting_pro_apoptotic_effect_between_freshly_isolated_and_precultured_human_monocytes_
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21492165/abstract/A_synthetic_cannabinoid_CP55940_inhibits_lipopolysaccharide_induced_cytokine_mRNA_expression_in_a_cannabinoid_receptor_independent_mechanism_in_rat_cerebellar_granule_cells_
Effect of cannabidiol treatment in alimentary induced fatty liver (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1278456
Cannabis could be used to treat epilepsy (news–2011) http://www.telegraph.co.uk/science/science-news/8440303/Cannabis-could-be-used-to-treat-epilepsy.html
top
Marijuana Extract Might Help Prevent Chemotherapy-Related Nerve Pain (news–2011) http://www.newswise.com/articles/marijuana-extract-might-help-prevent-chemotherapy-related-nerve-pain
Marijuana component could ease pain from chemotherapy drugs (news–2011) http://medicalxpress.com/news/2011-10-marijuana-component-ease-pain-chemotherapy.html
Another Study Confirms Anti-Cancer Effects of THC and CBD (news–2011) http://www.examiner.com/medical-marijuana-in-philadelphia/another-study-confirms-anti-cancer-effectsof-thc-and-cbd-1
Cannabinoid ‘Completely’ Prevents Chemotherapy-Induced Neuropathy, Study Says (news – 2011) http://norml.org/news/2011/10/19/cannabinoid-completely-prevents-chemotherapy-induced-neuropathystudy-says
Cannabidiol May Fight Alzheimer’s Disease (news-2011) http://www.examiner.com/medical-marijuana-in-philadelphia/cannabidiol-may-fight-alzheimer-sdisease?fb_comment=31078356
Marijuana Compound Induces Cell Death In Hard-To-Treat Brain Cancer (news–2011) http://norml.org/news/2011/01/20/marijuana-compound-induces-cell-death-in-hard-to-treat-brain-cancer
Marijuana component may ease pain from chemo therapy drugs (news–2011) http://www.jpost.com/Health/Article.aspx?id=241299
Pot Compound Exerts Anticonvulsant Effects In Animal Models Of Epilepsy (news-2011) http://www.norml.org/index.cfm?Group_ID=8458
CBD: Marijuana Compound Has No High, But Relieves Pain (news–2011) http://www.tokeofthetown.com/2011/10/cbd_marijuana_compound_has_no_high_but_relieves_pa.php
New research provides hope for those with epilepsy (news-2011) http://medicalxpress.com/news/2011-04-epilepsy.html
Cannabis Compound Induces Death Of Cells Associated With Liver Fibrosis (news–2011) http://norml.org/news/2011/06/30/cannabis-compound-induces-death-of-cells-associated-with-liver-fibrosis
CBD Tops The Chart (news-2011) http://morganlesko.com/cbd/2011/12/23/cbd-tops-the-chart/
Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy (news–2011) http://www.news-medical.net/news/20110926/Cannabidiol-may-help-prevent-paclitaxel-inducedperipheral-neuropathy.aspx
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (full–2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008&lng=en&nrm=iso&tlng=en
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice (full-2012) http://content.karger.com/produktedb/produkte.asp?DOI=000336871&typ=pdf
Towards the use of non-psychoactive cannabinoids for prostate cancer (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02121.x/pdf
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388241/
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1425/full
Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcomaassociated herpesvirus-infected endothelium (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527984/
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
top
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/?tool=pubmed
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912000052
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature (full–2012) http://www.harmreductionjournal.com/content/9/1/7
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures (full–2012) http://www.seizure-journal.com/article/S1059-1311%2812%2900057-X/fulltext
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents (full–2012) http://carcin.oxfordjournals.org/content/34/1/48.long
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398715/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full–2012)
http://www.sciencedirect.com/science/article/pii/S0014299912008485
Cannabidiol inhibits angiogenesis by multiple mechanisms (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504989/
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test (full–2012) http://www.sciencedirect.com/science/article/pii/S0278584612002801
Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol (link to PDF-2012) http://www.scirp.org/searchResult/Index.aspx?searchCode=Islet+protection+and+amelioration+of+diabetes+type+2+in+Psammomys+obesus+by+treatment+with+cannabidiol
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydro-cannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF–2012) http://www.eurekaselect.com/102848/article
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
top
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22726074
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22231745
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
The therapeutic potential of the endocannabinoid system for Alzheimer’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22448595
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22543671
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22580111
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22178458
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
Cannabidiol-induced apoptosis in murine microglial cells through lipid raft (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/glia.22345/abstract
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716160
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716148
The potential use of cannabidiol in the therapy of metabolic syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005
Cannabinoid-like anti-inflammatory compounds from flax fiber (abst–2012) http://link.springer.com/article/10.2478%2Fs11658-012-0023-6
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22815234
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22877651
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22659086
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT(1A) receptors in the dorsal raphe nucleus (abst–2012) http: /www.ncbi.nlm.nih.gov/pubmed/22862835
Phytocannabinoids as novel therapeutic agents in CNS disorders (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21924288
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23007604
top
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
What place for cannabis extract in MS? (abst–2012) http://dtb.bmj.com/content/50/12/141.abstract
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12018/abstract
Would some cannabinoids ameliorate symptoms of autism? (abst-2012) http://www.thctotalhealthcare.com/would-some-cannabinoids-ameliorate-symptoms-of-autism/
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22495620
MicroRNAs and their role in the generation of myeloid derived suppressor cells (MDSC) by cannabidiol in vivo (abst–2012) http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/48.16?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22627170
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures (abst–2012)
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
Study on Non-Psychotropic Cannabinoid Proves to be Safe in Humans (news–2012) http://www.opposingviews.com/i/society/drug-law/study-non-psychotropic-cannabinoid-proven-be-safehumans
Marijuana Compound May Beat Antipsychotics at Treating Schizophrenia (news–2012) http://psychcentral.com/news/2012/06/07/marijuana-compound-may-beat-antipsychotics-at-treatingschizophrenia/39803.html
Getting the Flax Straight about Cannabidiol (news–2012) http://www.examiner.com/article/getting-the-flax-straight-about-cannabidiol
Medical Marijuana: A “Cure” for Autism? (news–2012) http://bigbudsmag.com/lifestyle/medicine/article/medical-marijuana-cure-autism-january-2012
How marijuana could help cure obesity-related diseases (news–2012) http://news.yahoo.com/marijuana-could-help-cure-obesity-related-diseases-175900182.html
Cannabis can help treat obesity (news–2012) http://in.news.yahoo.com/cannabis-help-treat-obesity-121931025.html
Study: Cannabis Use Associated With Decreased Prevailence Of Diabetes (news–2012) http://norml.org/news/2012/12/20/study-cannabis-use-associated-with-decreased-prevalence-of-diabetes
Researchers study neuroprotective properties in cannabis (news-2012) http://www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-in-cannabis/
How Medical Marijuana Is Giving a Six-Year-Old Boy New Life (news–2012) http://thinkprogress.org/justice/2012/09/18/854811/how-medical-marijuana-is-giving-a-six-year-old-boynew-life/?mobile=nc
Marijuana compound could stop aggressive cancer metastasis (news-2012) http://in.news.yahoo.com/marijuana-compound-could-stop-aggressive-cancer-metastasis-064950912.html
Marijuana And Cancer: Scientists Find Cannabis Compound Stops Metastasis In Aggressive Cancers (news–2012) http://www.huffingtonpost.com/2012/09/19/marijuana-and-cancer_n_1898208.html
top
Can marijuana stop cancer? (news–2012) http://www.examiner.com/article/can-marijuana-stop-cancer
Cannabis For Infant’s Brain Tumor, Doctor Calls Child “A Miracle Baby” (news–2012) http://www.huffingtonpost.com/2012/12/01/cannabis-for-infants-brai_n_2224898.html
Buy It Now, It’s Legal – Medical Marijuana Cannabidiol (CBD from Industrial Hemp) (news-2012) http://beforeitsnews.com/health/2012/10/buy-it-now-its-legal-medical-marijuanacannabidiol-cbd-from-industrial-hemp-2453866.html
Israel pushing ahead in medical marijuana industry (news–2012) http://news.yahoo.com/israel-pushing-ahead-medical-marijuana-industry-180817891.html;_ylt=A2KJjbz3o5RQ4BcAYprQtDMD
Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news–2012) http://healthland.time.com/2012/05/30/marijuana-compound-treats-schizophrenia-with-few-side-effectsclinical-trial/
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news–2012) http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
5 Marijuana Compounds That Could Help Combat Cancer, Alzheimers, Parkinsons (If Only They Were Legal) (news–2012) http://www.alternet.org/drugs/5-marijuana-compounds-could-help-combat-cancer-alzheimers-parkinsonsif-only-they-were-legal
Encouraging anti-diabetic results for new cannabinoid drug (news–2012) http://www.diabetes.co.uk/news/2012/Dec/encouraging-anti-diabetic-results-for-new-cannabinoid-drug-99996010.html
Study: Marijuana Could Stop Growth of Colon Cancer Cells (news–2012) http://www.opposingviews.com/i/society/drug-law/latest-science-non-psychotropic-cannabinoid-inhibitscolon-cancer-cell
Is Marijuana the Cancer Cure We’ve Waited For? (news–2012) http://www.empowher.com/cancer/content/marijuana-cancer-cure-we-ve-waited
The Amazing Health Benefits of Juicing Raw Cannabis Leaves (news–2012) http://www.wakingtimes.com/2012/05/09/the-amazing-health-benefits-of-juicing-raw-cannabis-leaves/
Weaker Hemp Derivatives Can’t Compare to Full-Spectrum Marijuana Pills (news/ad- 2012) http://www.prweb.com/releases/marijuanapills/cannabispill/prweb10099535.htm
Simple Method: Isolating & Extracting INDIVIDUAL Cannabinoids… from BadKittySmiles (forum post–2012) http://forum.grasscity.com/incredible-edible-herb/1051569-simple-method-isolating-extracting-individualcannabinoids-badkittysmiles.html
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment resistant epilepsy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594064/
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/07/CBDcigarettes.pdf
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: proapoptotic effects and underlying mechanisms (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054795
Endocannabinoid system and mood disorders: Priming a target for new therapies (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584612002801
top
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877544/
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629308/
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses (full–2013) http://www.pnas.org/content/early/2013/03/06/1211204110.full.pdf+html
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full–2013) http://www.jleukbio.org/content/92/5/1093.full
Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797438/
Modulating the endocannabinoid system in human health and disease: successes and failures (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/febs.12260/pdf
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics (full–2013) http://www.jpsmjournal.com/article/S0885-3924%2812%2900439-3/fulltext
Cannabidiol as potential anticancer drug (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04298.x/pdf
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy (full–2013) http://iospress.metapress.com/content/4j61942x88175321/fulltext.html
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers (full–2013) http://www.springerplus.com/content/2/1/236
Is the cardiovascular system a therapeutic target for cannabidiol? (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04351.x/full
Role of endogenous cannabinoid system in the gut. (full – 2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076918
Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19 (full–2013) https://www.jstage.jst.go.jp/article/dmpk/28/4/28_DMPK-12-RG-129/_pdf
Is the cardiovascular system a therapeutic target for cannabidiol? (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04351.x/full
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
A review of the cultivation and processing of cannabis (Cannabis sativa L) for production of prescription medicines in the UK (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full–2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain (full–2013) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462013000400380&lng=en&nrm=iso&tlng=en
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
top
Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency (full–2013) http://www.nutricionhospitalaria.com/pdf/6430.pdf
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells (full–2013) http://mct.aacrjournals.org/content/12/1/69.long
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703206/
Transdermal delivery of cannabidiol Patent 8435556 (full–2013) https://www.google.com/patents/US8435556
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control) (full–2013) http://www.freepatentsonline.com/y2013/0245110.html
Transdermal delivery of cannabidiol Patent 8435556 (full–2013) https://www.google.com/patents/US8435556
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (full–2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2 (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/ijc.28591/full
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9 tetrahydrocannabinol (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838683/
Cannabidiol reverses the mCPP-induced increase in marble-burying behavior (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/fcp.12051/full
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptors activation in mice. (full – 2013) http://www.sciencedirect.com/science/article/pii/S0278584613001164
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/10/AntiCancer-Research-10-2013.pdf
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control) (full–2013) http://www.freepatentsonline.com/y2013/0245110.html
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants (link to PDF-2013) http://www.mdpi.com/1420-3049/18/10/12663
Industrial hemp decreases intestinal motility stronger than indian hemp in mice (link to PDF–2013) http://www.europeanreview.org/article/3266
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors (letter–2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900115-2/fulltext
Cannabidiol enhances consolidation of explicit fear extinction in humans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23307069
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343597
Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24088353
top
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22726074
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23587650
The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23644464
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23643693
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.9?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/1123.1?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23721741
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Do cannabinoids exhibit a tyramine-like effect? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23900610
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23924692
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23981015
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24030360
Protective effect of cannabidiol against cadmium hepatotoxicity in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23993482
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24120371
Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24140434
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. (abst – 2013)
http://www.ncbi.nlm.nih.gov/pubmed/24160757
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23517929
Cannabidiol in inflammatory bowel diseases: a brief overview. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22815234
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23343597
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23103902
top
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae) (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23926240
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24238999
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24288245
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24304686
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24321837
Cannabidiol as a potential treatment for psychosis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24309088
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray (abst-2013) http://onlinelibrary.wiley.com/doi/10.1002/cpdd.36/abstract
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23095052
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst-2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24373545
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22850623
Whole Cannabis Extracts of High Concentration Cannabidiol May Calm Seizures in Highly Refractory Pediatric Epilepsies (abst – 2013) http://hope4childrenwithepilepsy.com/wp-content/uploads/2013/11/Dr.-Gedde-Abstract.pdf
INTERVIEW : Martin Lee of Project CBD (interview–2013) http://www.ladybud.com/2013/11/12/interview-martin-lee-of-project-cbd/
Study: Cannabis Compound Reduces Cigarette Consumption In Tobacco Smokers (news–2013) http://blog.norml.org/2013/07/03/study-cannabis-compound-reduces-cigarette-consumption-in-tobaccosmokers/#sthash.zlfKQZlj.dpuf
Terpenes May Improve Effectiveness Of Medical Marijuana (news–2013) http://www.medicaljane.com/2013/09/23/terpenes-may-improve-effectiveness-of-medical-marijuana/#
Marijuana Verses Leading Pharmaceuticals In The Treatment of Colon Cancer (news–2013) http://www.wakingtimes.com/2013/05/06/marijuana-verses-leading-pharmaceuticals-in-the-treatment-ofcolon-cancer/
High on Health: Cannabinoids in the Food Supply (news – 2013) http://www.wakingtimes.com/2013/04/25/high-on-health-cbd-in-the-food-supply/
top
Fighting Cancer: Another Study Reveals the Cannabis and Cancer Link (news – 2013) http://www.wakingtimes.com/2012/10/05/fighting-cancer-another-study-reveals-the-cannabis-and-cancerlink/
Parents of epileptic N.J. tot lament medical marijuana delays (news – 2013) http://articles.philly.com/2013-06-24/news/40148313_1_marijuana-law-marijuana-card-dispensary
Charlotte’s Web Of Suffering: Six-Year-Old Colorado Girl With Dravet Syndrome Finds Relief From Marijuana High In CBD (news – 2013) http://www.marijuana.com/news/2013/06/charlottes-web-of-suffering-six-year-old-colorado-girl-withdravet-syndrome-finds-relief-from-marijuana-high-in-cbd/
Toronto family hopes for access to controversial treatment to cure baby’s rare epilepsy (news – 2013) http://globalnews.ca/news/714104/toronto-family-hopes-for-access-to-controversial-treatment-to-curebabys-rare-epilepsy/
Cannabis may help reverse dementia: study (news – 2013) http://www.bordermail.com.au/story/1283217/cannabis-may-help-reverse-dementia-study/?cs=7
Mother Investigated After Opting For Marijuana Over Chemotherapy (news – 2013) http://denver.cbslocal.com/2013/09/27/springs-mother-investigated-after-opting-for-marijuana-overchemotherapy/
Sending multiple sclerosis up in smoke (news – 2013) http://www.eurekalert.org/pub_releases/2013-10/afot-sms100713.php
Chemicals in marijuana ‘protect nervous system’ against MS (news – 2013) http://www.medicalnewstoday.com/articles/267161.php
Families migrate to Colorado for marijuana miracle (news – 2013) http://www.denverpost.com/fitness/ci_24498723/families-migrate-colorado-marijuana-miracle?source=rss
Comes Now Epidiolex (FDA approves IND studies of CBD) (news – 2013) http://www.beyondthc.com/comes-now-epidiolex-fda-approves-ind-studies-of-cbd/
Epidiolex (news – 2013) http://www.gwpharm.com/Epidiolex.aspx Pharmaceuticals Provides Update on Orphan Program in Childhood Epilepsy for
Epidiolex® (news–2013) http://www.gwpharm.com/GW%20Pharmaceuticals%20Provides%20Update%20on%20Orphan%20Program%20in%20Childhood%20Epilepsy%20for%20Epidiolex.aspx
Cannabis-Based Epilepsy Drug Approved For Clinical Trials (news – 2013) http://www.medicaljane.com/2013/10/23/cannabis-based-epilepsy-drug-approved-for-clinical-trials/
CBD as a potential treatment for intractable epilepsy/ Obtaining Epidiolex™ in the US (news – 2013) http://www.iowa.gov/odcp/docs/DravetFoundationnewsletteronCBD-IND-EpidiolexOct2013.pdf
Can Marijuana Help You Quit Cigarettes? Study Says Yes (news–2013) http://www.leafscience.com/2013/11/01/can-marijuana-help-quit-cigarettes-study-says-yes/
Can The Cannabis Component Cannabidiol (CBD) Cure Schizophrenia? (news – 2013) http://www.examiner.com/article/can-the-cannabis-component-cannabidiol-cbd-cureschizophrenia?cid=PROD-redesign-right-next
Study shows non-hallucinogenic cannabinoids are effective anti-cancer drugs (news–2013) http://www.alphagalileo.org/ViewItem.aspx?ItemId=135404&CultureCode=en
New Study Proves Cannabinoids Have Cancer Fighting Properties (news – 2013) http://www.opposingviews.com/i/society/drug-law/new-study-proves-cannabinoids-have-cancer-fightingproperties
top
Marijuana Extract Holds Promise as Diabetes Treatment (news – 2013) http://www.newsmax.com/Health-News/Type-2-diabetes-diabetes-drugs-marijuana-experimental-drugGWP42004/2013/07/19/id/516015
CBD strains from Europe Grown Out in California (news – 2013) http://www.beyondthc.com/wp-content/uploads/2013/11/CBD-2013.pdf
High levels of THC in Australian cannabis (news – 2013) http://medicalxpress.com/news/2013-07-high-thc-australian-cannabis.html
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969077/
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (full-2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
Phytocannabinoids and epilepsy (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full-2014) http://www.karger.com/Article/FullText/357742
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full–2014) http://www.jci.org/articles/view/64628
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. (full – 2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/
Cyclosporine and Herbal Supplement Interactions (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913293/
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Cannabis and Cannabinoids (PDQ®)- National Cancer Institute (full-2014) http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page4
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full-2014) http://ajpgi.physiology.org/content/307/2/G140
The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet (full-2014) http://www.jpp.krakow.pl/journal/archive/08_14/pdf/487_08_14_article.pdf
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0113161
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112960/
The case for medical marijuana in epilepsy (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Cannabinoids for epilepsy (full-2014) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009270.pub3/full
top
The case for assessing cannabidiol in epilepsy (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12635/full
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997281/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
A protocol for the delivery of cannabidiol (CBD) and combined CBD and [increment]9-tetrahydrocannabinol (THC) by vaporisation (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways (full-2014) http://www.karger.com/Article/Pdf/367615
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (full – 2014) http://www.karger.com/Article/Pdf/367615
Potential effects of cannabidiol as a wake-promoting agent. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023456/
Endocannabinoid signalling and the deteriorating brain. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=2233
Medical Cannabis Research, What the Science Says (article – 2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosisrelated spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24464350
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642454
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25024347
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24699310
Therapeutic Satisfaction and Subjective Effects of Different Strains of PharmaceuticalGrade Cannabis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24800644
top
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24845114
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. (abst – 2014)
http://www.ncbi.nlm.nih.gov/pubmed/24910342
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24976505
The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25029033
The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington’s disease may depend on their functional selectivity (abst – 2014) http://www.fasebj.org/content/28/1_Supplement/846.6.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells (abst – 2014) http://www.fasebj.org/content/28/1_Supplement/1048.19.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINEACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069049
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
Cannabidiol improves vasorelaxation in Zucker Diabetic fatty rats through cyclooxygenase activation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25212218
Cannabinoid-induced changes in respiration of brain mitochondria. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25195527
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25220020
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25237116
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25282526
Cannabidiol and endogenous opioid peptide-mediated mechanisms modulate antinociception induced by transcutaneous electrostimulation of the peripheral nervous system. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25282545
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25356537
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25398831
top
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9-tetrahydrocannabinol in Sprague-Dawley rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25425111
Cannabinoids and schizophrenia: therapeutic prospects. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
Cannabinoids in experimental stroke: a systematic review and meta-analysis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25492113
Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25498928
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Potential applications of marijuana and cannabinoids in medicine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25485642
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25037227
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
The Miracle Worker (news-2014) http://ireadculture.com/article-3695-the-father-of-modern-medical-cannabis-research-returns-with-an-allbut-impossible-new-study-of-cannabis-on-humans.html
Non-psychoactive CBD oil made from marijuana plants poised to be game-changer (news-2014) http://www.denverpost.com/marijuana/ci_25450052/cbd-marijuana-oil-changing-game?source=rss
This Family Had To Fire Their Doctor To Get Medical Marijuana For Their Son (news–2014) http://www.huffingtonpost.com/2014/03/25/epilepsy-medical-marijuana_n_5022008.html
Retired Flint couple sees the light on medical marijuana (news-2014) http://www.mlive.com/news/flint/index.ssf/2014/04/retired_flint_couple_sees_the.html
New Study: Cannabis May Protect Liver From Alcohol Related Damage (news-2014) https://thejointblog.com/new-study-cannabis-may-protect-liver-alcohol-related-damage/
Marijuana tested as treatment for children with epilepsy (news-2014) http://www.sfgate.com/health/article/Marijuana-tested-as-treatment-for-children-with-5246372.php?cmpid=twitter-mobile
Cannabis Science: Finding The Optimal Therapeutic Ratio Of THC And CBD (news – 2014) http://www.medicaljane.com/2014/05/29/finding-the-optimal-therapeutic-ratio-ofthc-and-cbd/#
THC, CBD And More: The Entourage Effect Of Whole-Plant Cannabis Medicine (news-2014) http://www.medicaljane.com/2014/05/14/thc-cbd-and-more-the-entourage-effect-of-whole-plant-cannabismedicine/
An Ingredient of Pot May Help People with Epilepsy (news-2014) http://www.scientificamerican.com/article/an-ingredient-of-pot-may-help-people-with-epilepsy/
top
Bid to Expand Medical Marijuana Business Faces Federal Hurdles (news – 2014) http://www.nytimes.com/2014/08/24/us/bid-to-expand-medical-marijuana-business-faces-federalhurdles.html?_r=0
Vaporized medical marijuana study given green light (news – 2014) http://abc7news.com/health/vaporized-medical-marijuana-study-given-green-light/261437/
Federal marijuana bill would legalize some cannabis strains (news – 2014) http://www.cnn.com/2014/07/28/health/federal-marijuana-bill/index.html
Low or No THC, High CBD Medical Marijuana Bills: Leaving Most Patients Behind (news–2014) https://www.mpp.org/low-or-no-thc-high-cbd-medical-marijuana-bills/
Cannabinoid Breakdown (news–2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Cannabis Chemistry 101 (news–2014) http://www.greencultured.co/cannabis-chemistry-101/
How Cannabis Might Keep Coronary Stents Open Longer (news – 2014) http://www.cbds.com/medicine/how-cannabis-might-keep-coronary-stents-open-longer/
DR ALLAN FRANKEL’S EARLY VERSION INITIAL DOSAGE AND ADMINISTRATION GUIDE (news–2014) http://www.greenbridgemed.com/dr-allan-frankels-early-version-initial-dosage-and-administration-guide/
Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment? (news–2014) (requires free registration) http://www.fool.com/investing/general/2014/09/13/is-medical-marijuana-destined-to-become-a-topschi.aspx
Marijuana Drastically Shrinks Aggressive Form Of Brain Cancer, New Study Finds (news–2014) http://www.huffingtonpost.com/2014/11/18/marijuana-brain-cancer_n_6181060.html
Cannabis extract can have dramatic effect on brain cancer, says new research (news–2014) http://medicalxpress.com/news/2014-11-cannabis-effect-brain-cancer.html
Why Marijuana Needs Chemical Quality Control Testing (news–2014) http://www.popsci.com/article/science/why-marijuana-needs-chemical-quality-control-testing
The new faces of marijuana (news – 2014) http://www.msnbc.com/hardball/the-new-faces-marijuana
Health Benefits Of Medical Marijuana: 3 Major Ways Cannabis Helps Sick People Live Normal Lives (news – 2014) http://www.medicaldaily.com/health-benefits-medical-marijuana-3-major-ways-cannabis-helps-sickpeople-live-normal-lives-283388
MEDICAL MARIJUANA : Out of the Shadows (news – 2014) http://cannabisclinicians.org/wp-content/uploads/2014/04/SCMA-Spring-2014-Kerr.pdf
Alzheimer’s Caused By Loss of Cannabinoids, Study Shows (news – 2014) http://www.leafscience.com/2014/06/23/alzheimers-caused-loss-cannabinoids-studyshows/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis
Cannabis May Protect The Aging Brain, Say Experts (news – 2014) http://www.leafscience.com/2014/05/07/cannabis-may-protect-aging-brain-say-experts/
New Research Shows How Marijuana Compound Can Reduce Tumor Growth In Cancer Patients (news – 2014) http://www.huffingtonpost.com/2014/07/16/marijuana-tumors_n_5588639.html
Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis. (full – 2015) http://static.smallworldlabs.com/molmedcommunity/content/pdfstore/14_261_Hao.pdf
top
Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD). (full – 2015) http://www.jbc.org/content/early/2015/02/09/jbc.M114.618447.long
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full – 2015) http://www.hindawi.com/journals/mi/2015/523418/
The cannabis conundrum: Thinking outside the THC box. (full – 2015) http://onlinelibrary.wiley.com/doi/10.1002/jcph.511/full
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full – 2015) http://www.hindawi.com/journals/mi/2015/349176/
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. (full – 2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma (full – 2015) http://www.nature.com/cddis/journal/v6/n1/full/cddis2014566a.html
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death (full – 2015) http://www.nature.com/jid/journal/v135/n6/pdf/jid201545a.pdf
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (full-2015) http://ijnp.oxfordjournals.org/content/18/5/pyu041.long
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. (full – 2015) http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full – 2015) http://tinyurl.com/ozojefv
Phytocannabinoids and epilepsy (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101681/
Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492759/
Current Status and Future of Cannabis Research (full – 2015) http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Cannabinoids: is there a potential treatment role in epilepsy? (full – 2015) http://informahealthcare.com/doi/pdf/10.1517/14656566.2015.1074181
The entourage effect: Synergistic actions of plant cannabinoids (letter – 2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/24853683
top
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25595882
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25680767
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25703248
A systematic review of the antipsychotic properties of cannabidiol in humans (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25667194
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25660577
Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25711828
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25701682
Cannabidiol, a Major Non-Psychotrophic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25801536
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption. (abst – 2015)
http://www.ncbi.nlm.nih.gov/pubmed/25799920
Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25820672
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. (abst – 2015)
http://www.ncbi.nlm.nih.gov/pubmed/25857324
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25882081
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stemlike cells proliferation by inducing autophagy in a TRPV2-dependent manner (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25903924
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25917103
top
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25943166
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Δ9-tetrahydrocannabinol in rat plasma (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26048666
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26033282
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids. (abst – 2015)
http://www.ncbi.nlm.nih.gov/pubmed/25537576
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) (abst – 2015)
http://www.ncbi.nlm.nih.gov/pubmed/26099242
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461530004X
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26197538
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26218440
Potency trends of Δ9 -THC, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-2015. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26234170
Cannabinoid and Terpene Info (chart – 2015) http://skunkpharmresearch.com/cannabinoid-info/
When Weed Is The Cure: A Doctor’s Case for Medical Marijuana (interview – 2015) http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana?utm_medium=RSS&utm_campaign=authorinterviews
How Medical Marijuana’s Chemicals May Protect Cells (news – 2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
San Francisco Medical Marijuana Clinic Says Cannabis is Effective for Many Women’s Medical Issues (news – 2015) http://www.prweb.com/releases/marijuana-doctor/san-francisco/prweb8668761.htm
Marijuana Could Be the Answer to Fighting These 3 Diseases (news–2015) (may require free registration) http://www.fool.com/investing/general/2015/01/10/marijuana-could-be-the-answer-to-fighting-these-3.aspx
Disabled JeffCo student’s cannabis medication confiscated, school cites federal law (news–2015) http://www.thedenverchannel.com/news/local-news/marijuana/disabled-jeffco-students-cannabismedication-confiscated-school-cites-federal-law
What is Hemp? (news – 2015) http://www.livescience.com/24552-what-is-hemp.html
top
How CBD Oil Changed Everything for a Dying Cat (news – 2015) http://dunksndank.com/cbd-mogli-the-cat-sick-treatment-nevada-medical-marijuana-pets/
Olympic athlete pushes for pot gold (news – 2015) http://www.bclocalnews.com/national/300827901.html
Cannabidiol paste potentially a cure for Lyme disease (news – 2015) http://www.bclocalnews.com/news/301163011.html
The Science Behind Sanjay Gupta’s WEED 3 (news – 2015) http://blog.sfgate.com/smellthetruth/2015/04/21/the-science-behind-sanjay-guptas-weed-3/
Withdrawal drug could help cannabis addicts kick the habit (news – 2015) http://www.newscientist.com/article/mg22630204.500-withdrawal-drug-could-help-cannabis-addicts-kickthe-habit.html?cmpid=RSS|NSNS|2012-GLOBAL|online-news#.VUuJV
Study confirms safety of cannabis drug CBD (news – 2015) https://www.epilepsy.org.uk/news/news/study-confirms-safety-cannabis-drug-cbd-64709
Controversial Cannabis Treatment Helps 9-Year-Old Boy Speak His First Words (news–2015) https://www.yahoo.com/parenting/controversial-cannabis-treatment-helps-9-year-old-120157532312.html
Warning Letters and Test Results (news – 2015) http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm435591.htm
New Study Shows Marijuana May Help Fight Cancer (news – 2015) http://finance.yahoo.com/news/study-shows-marijuana-may-help-53150501.html;_ylt=AwrXgiKcSoRVdnMAJ67QtDMD;_ylu=X3oDMTByM3V1YTVuBGNvbG8DZ3ExBHBvcwMzBHZ0aWQDBHNlYwNzcg–
Medical Marijuana Is Often Less Potent Than Advertised (news – 2015) http://www.npr.org/sections/health-shots/2015/06/23/416791647/medical-marijuana-is-often-less-potentthan-advertised One family’s medical-marijuana story (news – 2015) http://www.philly.com/philly/news/20150624_One_family_s_medical-marijuana_story.html
Study: Cannabis helps to heal bone fractures (news – 2015) http://www.upi.com/Health_News/2015/07/16/Study-Cannabis-helps-to-heal-bonefractures/9431437083214/
No bones about it: Cannabis may be used to treat fractures (news – 2015) http://medicalxpress.com/news/2015-07-bones-cannabis-fractures.html
Study: Cannabidiol (CBD) as an Effective Asthma Treatment (news – 2015) http://www.medicaljane.com/2015/06/17/research-suggests-cannabis-is-an-effective-asthma-treatment/
The Endocannabinoid System for Beginners (news–2015) http://cannabisnowmagazine.com/cannabis/medical/the-endocannabinoid-system-for-beginners


CBDA/CANNABIDIOLIC ACID
Medicinal Acidic Cannabinoids US Patent 7807711B2 (full–2010) http://www.cannabisinternational.org/info/Medicinal-Acidic-Cannabinoids.pdf
Cannabis as a Unique Functional Food (full–2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14 (full – 2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21975813/abstract/The_effects_of_cannabidiolic_acid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_
top
Cannabidiol May Fight Alzheimer’s Disease (news–2011) http://www.examiner.com/medical-marijuana-in-philadelphia/cannabidiol-may-fight-alzheimer-s-disease
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT(1A) receptor activation (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596650/
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDAMB-231 breast cancer cell migration (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009504/
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22233683
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682714/
Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24088353
Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24012649
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells (full-2014) https://www.jstage.jst.go.jp/article/jts/39/5/39_711/_pdf
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF-2014) http://www.mdpi.com/1420-3049/19/11/18781
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
Cannabinoid Breakdown (news–2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew) (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
top


CBDV/CANNABIDIVARIN
Cannabidivarin is anticonvulsant in mouse and rat (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02207.x/full
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy – Patent Applicaton #: #20120004251 (full– 2012) http://www.freshpatents.com/-dt20120105ptan20120004251.php
Phytocannabinoids as novel therapeutic agents in CNS disorders (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21924288
New Component of Cannabis Discovery Could Lead to Better Treatments for Epilepsy (news/ad–2012) http://www.gwpharm.com/New%20component%20of%20cannabis%20discovery%20could%20lead%20to%20better%20treatments%20for%20epilepsy.aspx
Science/UK: Antiepileptic efficacy of cannabidivarin will be tested in clinical studies (news–2012) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=382
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840466/
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792005/
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9 -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792004/
Cannabis Anti-Convulsant Shakes up Epilepsy Treatment (news – 2013) http://www.thecompassionchronicles.com/2013/01/26/cannabis-anti-convulsant-shakes-up-epilepsytreatment/
New cannabis discovery could lead to better treatments for epilepsy (news-2013) http://www.reading.ac.uk/news-and-events/releases/PR464765.aspx
New Study: Cannabinoids Protect the Brain and Heart From Injury (news-2013) http://www.science20.com/news_articles/thc_can_prevent_brain_damage_study-113512
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Phytocannabinoids and epilepsy (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25029033
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Phytocannabinoids and epilepsy (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26197538
top


CBG/CANNABIGEROL
Patent application title: THERAPEUTIC USES OF CANNABIGEROL (full-2010) http://www.faqs.org/patents/app/20100292345
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823359/?tool=pubmed
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
Medicinal Acidic Cannabinoids US Patent 7807711B2 (full – 2010) http://www.cannabisinternational.org/info/Medicinal-Acidic-Cannabinoids.pdf
Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20614687
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21243485
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessivecompulsive behaviour. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21796370
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa). (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21902175
Phytocannabinoids as novel therapeutic agents in CNS disorders (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21924288
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
5 Marijuana Compounds That Could Help Combat Cancer, Alzheimers, Parkinsons (If Only They Were Legal) (news–2012) http://www.alternet.org/drugs/5-marijuana-compounds-could-help-combat-cancer-alzheimers-parkinsonsif-only-they-were-legal
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23415610
top
The effect of CBG (BDS) botanical cannabinoid extract on MCF-7 human breast carcinoma cells (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1105.21?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23103902
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1336533
Study shows non-hallucinogenic cannabinoids are effective anti-cancer drugs (news–2013) http://www.alphagalileo.org/ViewItem.aspx?ItemId=135404&CultureCode=en
Terpenes May Improve Effectiveness Of Medical Marijuana (news – 2013) http://www.medicaljane.com/2013/09/23/terpenes-may-improve-effectiveness-of-medical-marijuana/#
New Study Proves Cannabinoids Have Cancer Fighting Properties (news – 2013) http://www.opposingviews.com/i/society/drug-law/new-study-proves-cannabinoids-have-cancer-fightingproperties
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642454
The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells (abst – 2014) http://www.fasebj.org/content/28/1_Supplement/1048.19.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2
Mice and 3-Nitropropionate-lesioned Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25252936
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis derived non-psychotropic cannabinoid. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25269802
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014)
http://www.ncbi.nlm.nih.gov/pubmed/25311884
Cannabinoid Breakdown (news–2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Cannabis Chemistry 101 (news–2014) http://www.greencultured.co/cannabis-chemistry-101/
Phytocannabinoids and epilepsy (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoid and Terpene Info (chart – 2015) http://skunkpharmresearch.com/cannabinoid-info/
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26197538
top


CBGA/CANNABIGEROLIC ACID
Medicinal Acidic Cannabinoids US Patent 7807711B2 (full – 2010) http://www.cannabisinternational.org/info/Medicinal-Acidic-Cannabinoids.pdf
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news–2012) http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
Affinity comparison of different THCA synthase to CBGA using modeling computational approaches (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916817/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF–2014) http://www.mdpi.com/1420-3049/19/11/18781
Cannabinoid Breakdown (news – 2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Production of Δ9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing Δ9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25994576
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837


CBN/CANNABINOL
Medicinal Acidic Cannabinoids US Patent 7807711B2 (full–2010) http://www.cannabisinternational.org/info/Medicinal-Acidic-Cannabinoids.pdf
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20117100
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22543671
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
5 Marijuana Compounds That Could Help Combat Cancer, Alzheimers, Parkinsons (If Only They Were Legal) (news–2012) http://www.alternet.org/drugs/5-marijuana-compounds-could-help-combat-cancer-alzheimers-parkinsonsif-only-they-were-legal
Transdermal delivery of cannabidiol Patent 8435556 (full – 2013) https://www.google.com/patents/US8435556
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24160757
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
top
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1336533
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuro-psychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke (full–2014) http://www.researchgate.net/publication/236185970_Hair_analysis_for_THCAA_THC_and_CBN_after_passive_in_vivo_exposure_to_marijuana_smoke
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF- 2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24699310
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25220020
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25498928
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
Potential applications of marijuana and cannabinoids in medicine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Cannabinoid Breakdown (news – 2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Cannabis Chemistry 101 (news – 2014) http://www.greencultured.co/cannabis-chemistry-101/
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function (full – 2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Phytocannabinoids and epilepsy (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoid and Terpene Info (chart – 2015) http://skunkpharmresearch.com/cannabinoid-info/
Comprehensive monitoring of the occurrence of 22 drugs of abuse and transformation products in airborne particulate matter in the city of Barcelona (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26081737
Potency trends of Δ9 -THC, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-2015. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26234170
top


C28H34N2O6
Identification of potential herbal inhibitor of acetylcholinesterase associated Alzheimer’s disorders using molecular docking and molecular dynamics simulation. (full – 2014) http://www.hindawi.com/journals/bri/2014/705451/


CHOCOLATE
Chocolate: The Good, the Bad and the Angry (news – 2010) http://www.psychologytoday.com/blog/your-brain-food/201011/chocolate-the-good-the-bad-and-the-angry
Cocoa and the Search for Dietary Cannabinoids (news – 2010) http://www.examiner.com/article/cocoa-and-the-search-for-dietary-cannabinoids
The Effects of Chocolate on the Body (news – 2010) http://www.livestrong.com/article/121084-effects-chocolate-body/
Migraines, Marijuana, and Chocolate (article – 2011) http://www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
Chocolate & marijuana: chemical cousins (news – 2011) http://www.examiner.com/drug-policy-in-reno/chocolate-marijuana-chemical-cousins
Sexuality, heart and chocolate (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23547364
Your Brain On Chocolate: Marijuana-Like Chemicals Explain Why We Crave It (news–2013)  http://www.truthonpot.com/2013/07/28/your-brain-on-chocolate-marijuana-like-chemicals-explain-whywe-crave-it/
Marijuana Is Less Addictive Than Chocolate (news – 2014) https://www.mainstreet.com/article/marijuana-less-addictive-chocolate


ECHINACEA
Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21764086
Comparison of shock wave therapy and nutraceutical composed of Echinacea angustifolia, alpha lipoic acid, conjugated linoleic acid and quercetin (perinerv) in patients with carpal tunnel syndrome (full–2015) http://iji.sagepub.com/content/early/2015/04/30/0394632015584501.long


ELIXINOL
Elixinol-Frequently Asked Questions (ad–undated) http://elixinol.eu/faq/ Teen to get medicinal marijuana treatment (news–2015) http://home.nzcity.co.nz/news/article.aspx?id=208058&fm=newsmain%2cnup


ENTOURAGE EFFECT–PHYTOCANNABINOIDS
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Terpenoids, ‘minor’ cannabinoids contribute to ‘entourage effect’ of cannabis-based medicines (news – 2011) http://www.scribd.com/doc/73090396/Terpenoids-%E2%80%98minor%E2%80%99-cannabinoidscontribute-to-%E2%80%98entourage-effect%E2%80%99-of-cannabis-based-medicines-O-Shaughnessy-sAutumn-2011
top
Cannabis entourage effect (news–2011) http://www.westcoastleaf.net/?p=3711
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news–2012) http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
Not That High (news–2013) http://www.slate.com/articles/health_and_science/science/2013/03/marijuana_potency_returning_smokers_want_mellower_pot_strains.html
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
THC, CBD And More: The Entourage Effect Of Whole-Plant Cannabis Medicine (news–2014) http://www.medicaljane.com/2014/05/14/thc-cbd-and-more-the-entourage-effect-of-whole-plant-cannabismedicine/
DR FRANKEL DISCUSSES THE “ENTOURAGE EFFECT” AND HEMP (news-2014) http://www.greenbridgemed.com/2014/03/12/dr-frankel-discusses-hemp-whole-plant-and-the-entourageeffect/
Medical marijuana and ‘the entourage effect’ (news-2014) http://www.cnn.com/2014/03/11/health/gupta-marijuana-entourage/index.html?eref=rss_mostpopular
Low or No THC, High CBD Medical Marijuana Bills: Leaving Most Patients Behind (news-2014) https://www.mpp.org/low-or-no-thc-high-cbd-medical-marijuana-bills/
THC, CBD And More: The Entourage Effect Of Whole-Plant Cannabis Medicine (news–2014) http://www.medicaljane.com/2014/05/14/thc-cbd-and-more-the-entourage-effect-of-whole-plant-cannabismedicine/
The surprising everyday ingredient that can reduce pot paranoia (news-2014) http://www.salon.com/2014/08/21/the_surprising_everyday_ingredient_that_can_reduce_pot_paranoia_partner/
Medical Marijuana: Much More Than Just THC and CBD (news-2014) http://www.medicaljane.com/2014/05/14/thc-cbd-and-more-the-entourage-effect-of-whole-plant-cannabismedicine/
The entourage effect: Synergistic actions of plant cannabinoids (letter-2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Cannabidiol, a Major Non-Psychotrophic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25801536
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25799920
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew). (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
Cannabinoids for the Treatment of Movement Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206230
EPIDIOLEX – a CBD-based extract used for epilepsy Epidiolex – GW Pharmaceuticals (drug development page–2013) http://www.gwpharm.com/Epidiolex.aspx
Pharmaceuticals Provides Update on Orphan Program in Childhood Epilepsy for Epidiolex® (news–2013) http://www.gwpharm.com/GW%20Pharmaceuticals%20Provides%20Update%20on%20Orphan%20Program%20in%20Childhood%20Epilepsy%20for%20Epidiolex.aspx
CBD as a potential treatment for intractable epilepsy/ Obtaining Epidiolex™ in the US (news–2013) http://www.iowa.gov/odcp/docs/DravetFoundationnewsletteronCBD-IND-EpidiolexOct2013.pdf
top
Comes Now Epidiolex (FDA approves IND studies of CBD) (news – 2013) http://www.beyondthc.com/comes-now-epidiolex-fda-approves-ind-studies-of-cbd/
Cannabis-Based Epilepsy Drug Approved For Clinical Trials (news – 2013) http://www.medicaljane.com/2013/10/23/cannabis-based-epilepsy-drug-approved-for-clinical-trials/
UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy (news – 2014) http://www.news-medical.net/news/20140205/UCSF-led-study-gathers-data-on-safety-tolerability-ofpurified-cannabinoid-for-children-with-epilepsy.aspx
Federal marijuana bill would legalize some cannabis strains (news–2014) http://www.cnn.com/2014/07/28/health/federal-marijuana-bill/index.html
A cannabis-based drug is showing ‘promise’ in children with severe epilepsy (news–2014) http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11161610/A-cannabisbased-drug-is-showing-promise-in-children-with-severe-epilepsy.html
Marijuana Could Be the Answer to Fighting These 3 Diseases (news-2015) (may require free registration) http://www.fool.com/investing/general/2015/01/10/marijuana-could-be-the-answer-to-fighting-these-3.aspx
Special Report: Georgia’s medical marijuana treatment trials underway (news-2015) http://www.41nbc.com/story/d/story/special-report-georgias-medical-marijuanatreatmen/13801/irDPjo2ogUiNaXQnsi-pnw
Study confirms safety of cannabis drug CBD (news–2015) https://www.epilepsy.org.uk/news/news/study-confirms-safety-cannabis-drug-cbd-64709
Big Pharma-Produced Cannabis Is Likely Coming to the U.S. (news – 2015) http://www.huffingtonpost.com/alice-oleary-randall/medical-cannabis-issue-th_b_7925956.html


FLAVONOIDS
Phytocannabinoids beyond the Cannabis plant – do they exist? (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Early Phenylpropanoid Biosynthetic Steps in Cannabis sativa: Link between Genes and Metabolites (full–2013) http://www.mdpi.com/1422-0067/14/7/13626/htm
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25492688
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25893829
Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26035635


HONKIOL
Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. (full – 2010) http://carcin.oxfordjournals.org/content/31/11/2004.long
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
top
Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of proinflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage (full – 2010) https://www.jstage.jst.go.jp/article/jphs/114/1/114_10070FP/_pdf
Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958642/
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220322/
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells (full – 2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123370/
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model (full – 2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018490
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells (full – 2011) http://www.nature.com/ijos/journal/v3/n1/pdf/ijos20116a.pdf
Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21621646
Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22126780
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21279327
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55 (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis (full-2012) http://breast-cancer-research.com/content/14/1/R35
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells (full-2012) http://mct.aacrjournals.org/content/11/4/963.long
Antimetastatic activity of honokiol in osteosarcoma. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1002/cncr.26434/full
Honokiol attenuates torsion/detorsion-induced testicular injury in rat testis by way of suppressing endoplasmic reticulum stress-related apoptosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22285174
Multiple effects of Honokiol on the life cycle of hepatitis C virus. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22098176
Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis. (abst – 2012)
http://www.ncbi.nlm.nih.gov/pubmed/22258232
Neuro-modulating effects of honokiol: a review. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769637/
Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813738/
Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523945/
Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of specificity protein 1. (full – 2013) http://www.spandidos-publications.com/ijo/43/4/1103?text=fulltext
top
Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/jor.22577/full
Honokiol as a Radiosensitizing Agent for Colorectal cancers (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844429/
Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition (full–2014) http://www.spandidospublications.com/ijo/44/1/187;jsessionid=D37A8D6D01845D28427059EB11FE132D?text=fulltext
Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244131/
Honokiol inhibits androgen receptor activity in prostate cancer cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946953/
Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA-MB231 breast cancer cells. (abst – 2014) ttp://www.ncbi.nlm.nih.gov/pubmed/24400594
Honokiol nanosuspensions: Preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24448177
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25459131
Effect of Honokiol on Proliferation and Apoptosis in HL-60 Cells and Its Potential Mechanism (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25543478
In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25516242
Honokiol inhibits melanoma stem cells by targeting notch signaling (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25491779
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25450590
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA). (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
Honokiol Decreases Intra-Abdominal Adhesion Formation in a Rat Model (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25632973


IDRASIL
Introducing Idrasil – The Marijuana Pill (ad–undated) http://idrasil.info/
New Cannabis Pill On Track for 2012 Debut (news–2011) http://www.theweedblog.com/new-cannabis-pill-on-track-for-2012-debut/
A legit cannabis pill!? You don’t say! (news–2011) http://hailmaryjane.com/a-legit-cannabis-pill-you-dont-say/
Cannabis Effective for Easing MS Symptoms, but Not for Slowing Progression (news–2012) http://www.prweb.com/releases/-medical-marijuana/-information-san-francisc/prweb9568927.htm
European Medical Marijuana product Sativex is challenged by North America’s New Cannabis Pill Idrasil, Says Doobons (news/ad-2012) http://www.prweb.com/releases/-medical-marijuana/-information-san-francisc/prweb9525356.htm
top
Weaker Hemp Derivatives Can’t Compare to Full-Spectrum Marijuana Pills (news/ad-2012) http://www.prweb.com/releases/marijuanapills/cannabispill/prweb10099535.htm
Orange County Manufacturer Leads the Nation in Medical Cannabis Innovation (news/ad- 2014) http://www.prweb.com/releases/2014/05/prweb11880009.htm


MAGNOLOL
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55 (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813752/
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments. (full – 2013) http://www.ddtjournal.com/action/downloaddoc.php?docid=687
Magnolol Ameliorates Ligature-Induced Periodontitis in Rats and Osteoclastogenesis: In Vivo and In Vitro Study (full – 2013) http://www.hindawi.com/journals/ecam/2013/634095/
Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice. (full – 2013) https://www.jstage.jst.go.jp/article/bpb/36/5/36_b12-00880/_html
Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the
PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells (full–2013) http://www.spandidos-publications.com/ijo/43/2/600
The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827615/
Magnolia extract, magnolol and metabolites: activation of cannabinoid CB2 receptors and blockade of the related GPR55 (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
Autophagy triggered by magnolol derivative negatively regulates angiogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920944/
Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/akt signaling pathways. (1st page – 2013) http://www.tandfonline.com/doi/abs/10.1080/01635581.2013.828082?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23053725
Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24147344
Magnolol inhibits colonic motility through down-regulation of voltage-sensitive L-type Ca(2+) channels of colonic smooth muscle cells in rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23972358
Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23943503
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation. (abst – 2013)
http://www.ncbi.nlm.nih.gov/pubmed/23906924
top
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23901038
Resuscitation from experimental traumatic brain injury by magnolol therapy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23721932
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells: magnolol inhibits LPS-induced inflammatory response. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23515857
Anti-hepatitis B virus lignans from the root of Streblus asper. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23434030
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells (abst – 2013)
http://www.ncbi.nlm.nih.gov/pubmed/23416116
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells (link to PDF–2014) http://www.mdpi.com/1420-3049/19/1/1223
Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA-MB231 breast cancer cells. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24400594
Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25641229
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25459131
In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype. (abst – 2014)
http://www.ncbi.nlm.nih.gov/pubmed/25516242
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by high-fat diet and streptozotocin (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24974464
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA). (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25173887


MELILOTUS SUAVEOLENS LEDAB/SWEET MELIOT
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/


NAMISOL
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394127/
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial (abst-2014)
http://www.ncbi.nlm.nih.gov/pubmed/25035121
top


4’-O-METHYLHONOKIOL
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20004682
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20974250
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full–2012) http://www.jneuroinflammation.com/content/9/1/135
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation. (full – 2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf


OLIVE OIL
Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25533906


PHYTOCANNABINOIDS/PLANT EXTRACTS
Cannabinoid and Terpenoid Reference Guide (undated) http://steephilllab.com/resources/cannabinoid-and-terpenoid-reference-guide/
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L (full–2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. (full – 2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931567/?tool=pubmed
Phytocannabinoids beyond the Cannabis plant – do they exist? (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/pdf/bcp0070-0656.pdf
AMELIORATIVE POTENTIAL OF CANNABIS SATIVA EXTRACT ON DIABETES INDUCED NEUROPATHIC PAIN IN RATS (full – 2010) http://www.ijpsr.com/V1I11/11%20Vol%201,%20Issue%2011,%20IJPSR,%20Paper%206.pdf
Antibacterial analysis of crude extracts from the leaves of Tagetes erecta and Cannabis sativa (full – 2010) http://www.ipublishing.co.in/ijesarticles/twelve/articles/voltwo/EIJES3150.pdf
Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20450962
top
Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19847654/abstract/Non_CB1_non_CB2_receptors_for_endocannabinoids_plant_cannabinoids_and_synthetic_cannabimimetics:_focus_on_G_protein_coupled_receptors_and_transient_receptor_potential_channels_
A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20975531
Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20349049
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform selective and potent inhibitors of human CYP1 enzymes. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20117100
Scientists Find New Sources of Plant Cannabinoids Other than Medical Marijuana? (news – 2010) http://montanabiotech.wordpress.com/2011/03/26/scientists-find-new-sources-of-plant-cannabinoids-otherthan-medical-marijuana/
Nature’s (Legal) Cannabinoids (news – 2010) http://www.mapinc.org/drugnews/v10/n126/a04.html?1194
Gut feelings about the endocannabinoid system (full – 2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full – 2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Prospects for cannabinoid therapies in basal ganglia disorders. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
Treatment of Crohn’s disease with cannabis: an observational study. (full – 2011) http://www.ima.org.il/FilesUpload/IMAJ/0/39/19985.pdf
The Endocannabinoid System: Plant-Derived Cannabinoids in Diabetes and Diabetic Complications. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349875/
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Effect of various concentrations of Crocus sativus and Cannabis sativa extracts on luminescent biosensor Escherichia coli SM10 S1 (full – 2011)
http://jjm.ajums.ac.ir/_jjm/documents/Issue%2012,%20S35-41MM.pdf
Cannabinoid-containing plant extracts as neuroprotective agents – Patent EP2332533 (A1) ― 2011-06-15 (full–2011) http://worldwide.espacenet.com/publicationDetails/description?CC=EP&NR=2332533A1&KC=A1&FT=
D&ND=3&date=20110615&DB=EPODOC&locale=en_EP
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A)―2011-09-14 (full – 2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21674569
The role of phytochemicals in the treatment and prevention of dementia (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21639405/abstract/The_role_of_phytochemicals_in_the_treatment_and_prevention_of_dementia_
top
Cannabinoids: occurrence and medicinal chemistry (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21254969/abstract/Cannabinoids:_occurrence_and_medicinal_chemistry_
Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21094240
Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21213357
Non-Δ9tetrahydrocannabinol phytocannabinoids stimulate feeding in rats (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22157176
EFFECT OF CANNABIS SATIVA ALCOHOLIC EXTRACT ON HIPPOCAMPUS NEURONAL DENSITY IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258946
EVALUATION ALLELOPATHIC EFFECT OF HEMP (CANNABIS SATIVA L.) ON GERMINATION AND GROWTH OF THREE KINDS OF WEEDS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=246119
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING (abst-2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=228000
EFFECT OF AQUATIC EXTRACT OFCANNABIS SATIVA LEAVES ON DEGENERATION OF ALPHA MOTONEURONS IN SPINAL CORD AFTER SCIATIC NERVE COMPRESSION IN RATS (abst – 2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258699
Natural Herbs That Increase Serotonin (news – 2011) http://www.livestrong.com/article/53343-natural-herbs-increase-serotonin/
Introduction to the Endocannabinoid System (news – 2011) http://norml.org/library/item/introduction-to-the-endocannabinoid-system
CBD Tops The Chart (news – 2011) http://morganlesko.com/cbd/2011/12/23/cbd-tops-the-chart/
Marijuana (Cannabis sativa) Mayo Clinic (news–2011) http://www.mayoclinic.com/health/marijuana/NS_patient-marijuana/DSECTION=evidence
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications (full – 2012) http://www.ncbinlm.nih.gov/pmc/articles/PMC3349875/
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Cannabinoid-associated cell death mechanisms in tumor models (Review) (full – 2012) http://www.spandidos-publications.com/ijo/41/2/407
Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report (full-2012) http://file.scirp.org/Html/9-2500130_16958.htm
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial (full–2012) http://jnnp.bmj.com/content/83/11/1125.long
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476512/
Phytocannabinoids as novel therapeutic agents in CNS disorders (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/21924288
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
Nature Against Depression (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22414105
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis. (abst – 2012)
http://www.ncbi.nlm.nih.gov/pubmed/25876933
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
top
Cannabis exposure associated with weight reduction and β-cell protection in an obese rat model (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22421529
Effect of extraction conditions on total polyphenol contents, antioxidant and antimicrobial activities of Cannabis sativa L (abst – 2012) http://www.cabdirect.org/abstracts/20123212113.html;jsessionid=DDBC2FF41C8322957AD4B468D3785A59?gitCommit=4.13.20-5-ga6ad01a
Non-Δ⁹tetrahydrocannabinol phytocannabinoids stimulate feeding in rats. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22157176
Marijuana: modern medical chimaera (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22873011
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures (abst – 2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
Studies on the Optimization of Agrotechniques to Maximize the Productivity of Two Cannabis Chemotypes Cultivated to Produce Medicinal Grade Plant Material (abst–2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1307524
NEUROPROTECTIVE EFFECTS OF CANNABIS SATIVA ALCOHOLIC EXTRACT AGAINST SPINAL ALPHA MOTONEURONS DEGENERATION IN MALE TYPE II DIABETIC RATS (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=278407
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news – 2012) http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
Weaker Hemp Derivatives Can’t Compare to Full-Spectrum Marijuana Pills (news/ad- 2012) http://www.prweb.com/releases/marijuanapills/cannabispill/prweb10099535.htm
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (full – 2013) http://iospress.metapress.com/content/4j61942x88175321/fulltext.html
Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332149/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: proapoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract. (full – 2013) http://www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
The pharmacologic and clinical effects of medical cannabis. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full – 2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
Cannabis, a complex plant: different compounds and different effects on individuals (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Towards a better Cannabis drug (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835116/
top
US Patent Application 20130059018 – PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full-2013) http://www.google.com/patents/US20130059018
Part I of the American Herbal Pharmacopoeia cannabis monograph (Preview) (full–2013) http://american-safe-access.s3.amazonaws.com/documents/AHP_Cannabis_Monograph_Preview.pdf
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study (full–2013) http://www.cghjournal.org/article/S1542-3565%2813%2900604-6/fulltext
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/ Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792005/
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules (full-2013) http://cannabisclinicians.org/wp-content/uploads/2013/10/AntiCancer-Research-10-2013.pdf
Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
The effect of CBG (BDS) botanical cannabinoid extract on MCF-7 human breast carcinoma cells (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1105.21?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms (abst-2013) http://www.unboundmedicine.com/medline/citation/24175484/The_medicinal_use_of_cannabis_and_cannabinoids–an_international_cross-sectional_survey_on_administration_forms.
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24373545
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1336533
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
Whole Cannabis Extracts of High Concentration Cannabidiol May Calm Seizures in Highly Refractory Pediatric Epilepsies (abst – 2013) http://hope4childrenwithepilepsy.com/wp-content/uploads/2013/11/Dr.-Gedde-Abstract.pdf
American Herbal Pharmacopoeia releases cannabis monograph legitimizing herb as botanical medicine (news – 2013) http://www.naturalnews.com/043288_cannabis_botanical_medicine_American_Herbal_Pharmacopoeia.html
Study shows non-hallucinogenic cannabinoids are effective anti-cancer drugs (news–2013) http://www.alphagalileo.org/ViewItem.aspx?ItemId=135404&CultureCode=en
New Study Proves Cannabinoids Have Cancer Fighting Properties (news – 2013) http://www.opposingviews.com/i/society/drug-law/new-study-proves-cannabinoids-have-cancer-fightingproperties
High on Health: Cannabinoids in the Food Supply (news – 2013) http://www.wakingtimes.com/2013/04/25/high-on-health-cbd-in-the-food-supply/
top
Cannabis fractions: Separating cannabinoids from terpenoids (news – 2013) http://www.separationsnow.com/details/ezine/13ec7586bd2/Cannabis-fractions-Separating-cannabinoidsfrom-terpenoids.html?tzcheck=1
Cannabis compounds may limit stroke damage (news – 2013) http://medicalxpress.com/news/2013-12-cannabis-compounds-limit.html
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http://www.neurology.org/content/82/17/1556.long
The case for medical marijuana in epilepsy. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Phytocannabinoids and epilepsy (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Current and future drugs for treatment of MS-associated bladder dysfunction (full–2014) http://www.sciencedirect.com/science/article/pii/S187706571401728X
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
A protocol for the delivery of cannabidiol (CBD) and combined CBD and [increment]9-tetrahydrocannabinol (THC) by vaporisation. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
Cannabinoids and schizophrenia: therapeutic prospects. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24373545
Cannabis for inflammatory bowel disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24969296
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable MeteredDose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25118789
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25135301
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Early phytocannabinoid chemistry to endocannabinoids and beyond. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25315390
Potential applications of marijuana and cannabinoids in medicine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Re-branding cannabis: the next generation of chronic pain medicine? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst – 2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
THC, CBD And More: The Entourage Effect Of Whole-Plant Cannabis Medicine (news–2014) http://www.medicaljane.com/2014/05/14/thc-cbd-and-more-the-entourage-effect-of-whole-plant-cannabismedicine/
Medical Marijuana: The Entourage Effect (news – 2014) http://www.leafscience.com/2014/09/11/medical-marijuana-entourage-effect/
The Entourage Effect: Why Whole Cannabis Is Better (news – 2014) http://www.unitedpatientsgroup.com/blog/2014/04/22/the-entourage-effect-why-whole-cannabis-is-better/
Cannabis Science: Finding The Optimal Therapeutic Ratio Of THC And CBD (news–2014) http://www.medicaljane.com/2014/05/29/finding-the-optimal-therapeutic-ratio-ofthc-and-cbd/#
top
Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients (news-2014) http://blog.norml.org/2014/08/18/study-cannabis-inhaler-delivers-effective-relief-to-neuropathy-patients/
2,500-Year-Old ‘Siberian Princess’ Corpse Shows Breast Cancer, Medicinal Pot Use (news–2014) http://www.inquisitr.com/1542721/2500-year-old-siberian-princess-corpse-showsbreast-cancer-medicinal-pot-use/
Cannabinoid Breakdown (news – 2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Cannabis Chemistry 101 (news – 2014) http://www.greencultured.co/cannabis-chemistry-101/
DR ALLAN FRANKEL’S EARLY VERSION INITIAL DOSAGE AND ADMINISTRATION GUIDE (news–2014) http://www.greenbridgemed.com/dr-allan-frankels-early-version-initial-dosage-and-administration-guide/
MEDICAL MARIJUANA : Out of the Shadows (news – 2014) http://cannabisclinicians.org/wp-content/uploads/2014/04/SCMA-Spring-2014-Kerr.pdf
Phytocannabinoids and epilepsy (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoids in late-onset Alzheimer’s disease. (full – 2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.117/full
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full – 2015) http://tinyurl.com/pe7eb73
Current Status and Future of Cannabis Research (full – 2015) http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Cannabinoids: is there a potential treatment role in epilepsy? (full – 2015) http://informahealthcare.com/doi/pdf/10.1517/14656566.2015.1074181
The entourage effect: Synergistic actions of plant cannabinoids (letter – 2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Cannabinoid and Terpene Info (chart – 2015) http://skunkpharmresearch.com/cannabinoid-info/
Enzymatic and biochemical changes in common carp, Cyprinus carpio (L.) fingerlings exposed to crude leaf extract of Cannabis sativa (L.) (abst – 2015) http://www.sciencedirect.com/science/article/pii/S2222180814606368
Options for pharmacoresistant epilepsy in children: when medications don’t work (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25658218
Endocannabinoids are conserved inhibitors of the Hedgehog pathway. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25733905
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25655949
The therapeutic potential of cannabinoids for movement disorders. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25649017
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
The role of cannabinoids in adult neurogenesis. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25951750
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Minor oxygenated cannabinoids from high potency Cannabis sativa L. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26093324
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26179998
Cannabinoids for the Treatment of Movement Disorders. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26206230
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26238742
top
Whole-Plant Cannabis Use Associated with Decreased Likelihood of Developing Bladder Cancer (news-2015) http://www.medicaljane.com/2015/01/31/cannabis-use-associated-with-decreased-likelihood-ofdeveloping-bladder-cancer/


SATIVEX/NABIXIMOLS
Summary of Product Characteristics- Sativex Oralmucosal Spray (full – 2010) http://www.medicines.org.uk/EMC/medicine/23262/SPC/Sativex+Oromucosal+Spray/
Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists (link to PDF-2010) http://www.eurekaselect.com/85221/article
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (abst-2010) http://msj.sagepub.com/cgi/content/abstract/16/6/707?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
Medical marijuana aka Sativex now available in UK (news-2010) http://www.examiner.com/article/medical-marijuana-aka-sativex-now-available-uk
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. (full– 2011) http://www.clinchem.org/content/57/1/66.long
Subjective and physiological effects after controlled Sativex and oral THC administration (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836266/
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to PDF-2011) http://www.dovepress.com/articles.php?article_id=7675
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21542664
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21671456
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis (abst-2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
top
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’ (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21674569
The Therapeutic Potential of Cannabis and Cannabinoids (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols). (full – 2012) http://msj.sagepub.com/content/18/2/219.long
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Towards the use of non-psychoactive cannabinoids for prostate cancer. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02121.x/pdf
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612560/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full – 2012)
http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Treatment of Tourette syndrome with cannabinoids. (link to PDF – 2012) http://www.hindawi.com/journals/bn/2013/294264/abs/
Cannabinoids: Novel Medicines for the Treatment of Huntington’s Disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22280340
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S1526590012000193
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716155
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22583441
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861
top
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23072659
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
What place for cannabis extract in MS? (abst – 2012) http://dtb.bmj.com/content/50/12/141.abstract
Neuromodulators for pain management in rheumatoid arthritis (abst – 2012) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Cannabinoid formulation benefits opioid-refractory pain (news – 2012) http://medicalxpress.com/news/2012-06-cannabinoid-benefits-opioid-refractory-pain.html
Cannabinoid Shown Effective as Adjuvant Analgesic for Cancer Pain (news – 2012) http://www.sciencedaily.com/releases/2012/06/120604142426.htm
Pot-based prescription drug looks for FDA OK (news – 2012) http://medicalxpress.com/news/2012-01-pot-based-prescription-drug-fda.html
Cannabinoid therapy helps provide effective analgesia for cancer patients with pain (news–2012) http://www.news-medical.net/news/20120605/Cannabinoid-therapy-helps-provide-effective-analgesia-forcancer-patients-with-pain.aspx
Marijuana Mouth Spray: Will It Be Abused? (news–2012) http://news.discovery.com/human/medical-marijuana-spray-120131.htm
Can medical marijuana help rheumatoid arthritis? (news – 2012) http://www.health.com/health/condition-article/0,,20499017,00.html
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (full – 2013) http://iospress.metapress.com/content/4j61942x88175321/fulltext.html
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers (full – 2013) http://www.springerplus.com/content/2/1/236
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
The pharmacologic and clinical effects of medical cannabis. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. (full – 2013) http://www.jpsmjournal.com/article/S0885-3924%2812%2900439-3/fulltext
Multiple sclerosis and the blood-central nervous system barrier. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain (full – 2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900238-8/fulltext
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22726074
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
top
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23621668
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1002/cpdd.36/abstract
Sativex® rescheduled by the Home Office (news – 2013) (click “yes” if asked) http://www.hospitalpharmacyeurope.com/latest-news/sativex-rescheduled-home-office
Adequate and Well-Controlled Studies Proving Medical Efficacy of Cannabis Exist but Are Ignored by Marijuana Schedulers (news – 2013) http://www.huffingtonpost.com/sunil-kumar-aggarwal/marijuana-schedule-1_b_3071725.html
“Miracle” Cannabis Oil: May Treat Cancer, But Money and the Law Stand in the Way of Finding Out (news – 2013) http://www.sfweekly.com/2013-04-24/news/key-words-cannabis-oil-cure-cancer-constance-finley/
Medical Marajuana: Consortium of Multiple Sclerosis Centers (news – 2013) http://www.msviews.org/msviewsandnews4/index.php/2012-05-28-00-15-54/2012-07-04-00-19-28/610-medical-marajuana-consortium-of-multiple-sclerosis-centers
Aylsham multiple sclerosis sufferer says cannabis-based drug ‘changed my life’ (news-2013) http://www.eveningnews24.co.uk/news/aylsham_multiple_sclerosis_sufferer_says_cannabis_based_drug_changed_my_life_1_2276182
The Great GW Pharma Confidence Trick. (news – 2013) http://www.clear-uk.org/the-great-gw-pharma-confidence-trick/
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full – 2014) http://www.karger.com/Article/FullText/357742
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http://www.neurology.org/content/82/17/1556.long
Getting high on the endocannabinoid system. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Medical marijuana for cancer. (full – 2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial. (full – 2014) http://archpsyc.jamanetwork.com/article.aspx?articleid=1812720
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (full – 2014) http://www.karger.com/Article/Pdf/367615
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary. (full – 2014)
http://www.clinicaltherapeutics.com/article/S0149-2918%2814%2900684-5/fulltext
Endocannabinoid signalling and the deteriorating brain. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Medical Cannabis Research, What the Science Says (article – 2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosisrelated spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
top
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24699310
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Cannabinoid mouth spray brought help to a severely spastic young man (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25158585
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
3 Prescription Drugs You Didn’t Know Come From Marijuana (news – 2014) http://www.fool.com/investing/general/2014/03/16/3-prescription-drugs-you-didnt-know-come-frommari.aspx
No Relief Yet for Brutal Oral Cancer Pain, but Cannabinoids May Offer Some Hope (news – 2014) http://www.newswise.com/articles/view/617125/?sc=rsmn
Cannabis Science: Finding The Optimal Therapeutic Ratio Of THC And CBD (news–2014) http://www.medicaljane.com/2014/05/29/finding-the-optimal-therapeutic-ratio-ofthc-and-cbd/#
Marijuana Benefits MS Patients as Other Remedies Fail (news – 2014) http://www.bloomberg.com/news/2014-03-24/marijuana-benefits-ms-patients-as-other-remedies-fail.html
Cannabis May Protect The Aging Brain, Say Experts (news – 2014) http://www.leafscience.com/2014/05/07/cannabis-may-protect-aging-brain-say-experts/
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ane.12287/full
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death (full–2015) http://www.nature.com/jid/journal/v135/n6/pdf/jid201545a.pdf
top
Sativex in the management of multiple sclerosis-related spasticity: role of the corticospinal modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25777582
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis (abst–2015) http://informahealthcare.com/doi/abs/10.1586/14737175.2015.1067607
How Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
Marijuana Gears Up for Production High in U.S. Labs (news–2015) http://www.scientificamerican.com/article/marijuana-gears-up-for-production-high-in-u-s-labs/
Family seeking cannabinoid spray prescription say many more could benefit (news–2015) http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11490218&ref=rss


TEA (Camellia sinensis L)
Tea catechins’ affinity for human cannabinoid receptors (full–2010) http://www.thefreelibrary.com/Tea+catechins%27+affinity+for+human+cannabinoid+receptors.-a0221094461
Effects of Hemp (Cannabis sativa L) Seed Oil Press-Cake and Decaffeinated Green Tea Leaves (Camellia sinensis) on Functional Characteristics of Gluten-Free Crackers (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24527987


TERPENOIDS/TERPENES
Cannabinoid and Terpenoid Reference Guide (undated) http://steephilllab.com/resources/cannabinoid-and-terpenoid-reference-guide/
Terpenes, Terpenoids and Cannabis (news – 2010) http://berkeleypatientscare.com/2010/10/08/terpenes-terpenoids-and-cannabis/
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Terpenoids, ‘minor’ cannabinoids contribute to ‘entourage effect’ of cannabis-based medicines (news–2011) http://www.scribd.com/doc/73090396/Terpenoids-%E2%80%98minor%E2%80%99-cannabinoidscontribute-to-%E2%80%98entourage-effect%E2%80%99-of-cannabis-based-medicines-O-Shaughnessy-sAutumn-2011
The Importance Of Matured Cannabis (news – 2011) http://www.clear-uk.org/the-importance-of-matured-cannabis/
Terpenoid biosynthesis in trichomes—current status and future opportunities (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-7652.2012.00737.x/full
top
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
THE EFFECTS OF JAMONATE ON PLASTIDAL TERPENOIDS ON CANNABIS SATIVA L. AT VEGETATIVE STAGE (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=305238
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news–2012) http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
The endocannabinoid system, cannabinoids, and pain (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Mangoes Elevate High From Smoking Marijuana: Are They A Healthier Alternative To The ‘Munchies’? (news – 2013) http://www.medicaldaily.com/mangoes-elevate-high-smoking-marijuana-are-they-healthier-alternativemunchies-247892
High on Health: Cannabinoids in the Food Supply (news – 2013) http://www.wakingtimes.com/2013/04/25/high-on-health-cbd-in-the-food-supply/
Terpene Isolation Could Be The Future Of Cannabis (news – 2013) http://www.medicaljane.com/2013/10/30/terpene-isolation-could-be-the-future-of-cannabis/
Not That High (news-2013) http://www.slate.com/articles/health_and_science/science/2013/03/marijuana_potency_returning_smokers_want_mellower_pot_strains.html
Cannabis fractions: Separating cannabinoids from terpenoids (news-2013) http://www.separationsnow.com/details/ezine/13ec7586bd2/Cannabis-fractions-Separating-cannabinoidsfrom-terpenoids.html?tzcheck=1
Terpenes May Improve Effectiveness Of Medical Marijuana (news – 2013) http://www.medicaljane.com/2013/09/23/terpenes-may-improve-effectiveness-of-medical-marijuana/#
The Same Compounds Behind Marijuana’s Distinctive Stinky Smells Give Clues About the Kinds of High You’ll Experience (news–2013) http://www.alternet.org/drugs/same-compounds-behind-marijuanas-distinctive-stinky-smells-give-cluesabout-kinds-high-youll
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988329/
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel Biosignaling Systems (abst-2014) http://pubs.acs.org/doi/abs/10.1021/cn5000875
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst-2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
THC, CBD And More: The Entourage Effect Of Whole-Plant Cannabis Medicine (news-2014) http://www.medicaljane.com/2014/05/14/thc-cbd-and-more-the-entourage-effect-of-whole-plant-cannabismedicine/
Cannabis Science: Finding The Optimal Therapeutic Ratio Of THC And CBD (news-2014) http://www.medicaljane.com/2014/05/29/finding-the-optimal-therapeutic-ratio-ofthc-and-cbd/#
How Black Pepper relieves Cannabis Anxiety (news – 2014) http://cannabisdigest.ca/black-pepper-relieves-cannabis-anxiety/
HolyWater, Live Resin, and The Future Of Terpene-Rich Cannabis Concentrates (news–2014) http://www.medicaljane.com/2014/07/25/holywater-live-resin-and-the-future-of-terpene-rich-cannabisconcentrates/
The surprising everyday ingredient that can reduce pot paranoia (news-2014) http://www.salon.com/2014/08/21/the_surprising_everyday_ingredient_that_can_reduce_pot_paranoia_partner/
top
DNA Genetic’ L.A. Confidential strain used on childhood autism (news-2014) http://blog.sfgate.com/smellthetruth/2014/10/30/dna-genetics-l-a-confidential-strain-used-on-childhoodautism/
Cannabis Chemistry 101 (news–2014) http://www.greencultured.co/cannabis-chemistry-101/
DR ALLAN FRANKEL’S EARLY VERSION INITIAL DOSAGE AND ADMINISTRATION GUIDE (news–2014) http://www.greenbridgemed.com/dr-allan-frankels-early-version-initial-dosage-and-administration-guide/
MEDICAL MARIJUANA : Out of the Shadows (news – 2014) http://cannabisclinicians.org/wp-content/uploads/2014/04/SCMA-Spring-2014-Kerr.pdf
Phytocannabinoids and epilepsy (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Cannabinoid and Terpene Info (chart–2015) http://skunkpharmresearch.com/cannabinoid-info/
BeerSci: What’s The Connection Between Hops And Marijuana? Because they sure look and smell alike (news–2015) http://www.popsci.com/science/article/2012-11/beersci-marijuana-related-hops


THC/TETRAHYDROCANNABINOL
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917429/?tool=pmcentrez
Antitumorigenic Effects of Cannabinoids beyond Apoptosis (full-2010) http://jpet.aspetjournals.org/content/332/2/336.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Therapeutical use of the cannabinoids in psychiatry (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010007500015&lng=en&nrm=iso&tlng=en
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131805/
Nutritional Interventions for Cancer-induced Cachexia (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106221/
top
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by HighPerformance Liquid Chromatography-Tandem Mass Spectrometry (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full – 2010) http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
Modulation of Adipocyte Biology by Δ9-Tetrahydrocannabinol (full – 2010) http://onlinelibrary.wiley.com/doi/10.1038/oby.2010.100/full
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882293/pdf/nihms200194.pdf
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967639/
Regulation of nausea and vomiting by cannabinoids (full – 2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01176.x/pdf
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014410/
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. (full – 2010) http://bjp.rcpsych.org/content/197/4/285.long
THC Prevents MDMA Neurotoxicity in Mice (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (full–2010) http://ijnp.oxfordjournals.org/content/13/7/861.long
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) (full–2010) http://ijnp.oxfordjournals.org/content/13/7/905.long
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (full-2010) http://www.jpsmjournal.com/article/S0885-3924%2809%2900787-8/fulltext
Anti-tumoural effects of cannabinoid combinations – Patent TW201002315 (A)―2010-01-16 (full – 2010) http://worldwide.espacenet.com/publicationDetails/description?CC=TW&NR=201002315A&KC=A&FT=D&ND=3&date=20100116&DB=EPODOC&locale=en_EP
Combination Of Cannabinoids For The Treatment Of Peripheral Neuropathic Pain US 2010/ 0035978 A1 Feb. 11, 2010 (full – 2010) http://www.cannabisinternational.org/info/Neuropathic-Pain.pdf
US Patent 7674922 B2 Process for production of delta-9-tetrahydrocannabinol (full-2010) http://www.google.com/patents/US7674922
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting (link to PDF–2010) http://www.mdpi.com/1424-8247/3/9/2930
Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists (link to PDF–2010) http://www.eurekaselect.com/85221/article
Delta-9-Tetrahydrocannabinol Disruption of Time Perception and of Self-Timed Actions (letter-2010) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0030-1255030
Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20516734
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: antiinvasion activity at low concentration and apoptosis induction at high concentration (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19916793
top
The results of an experimental indoor hydroponic Cannabis growing study, using the ‘Screen of Green’ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20462712
Chronic cannabinoid administration lowers viral replication in lymph nodes of SIV infected Rhesus macaques (abst-2010) http://www.fasebj.org/cgi/content/meeting_abstract/24/1_MeetingAbstracts/752.6?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=720&resourcetype=HWCIT
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20498181
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform selective and potent inhibitors of human CYP1 enzymes (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20117100
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst – 2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
Oral Delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20520294
Tocolytic Effect of Δ9-Tetrahydrocannabinol in Mice Model of Lipopolysaccharide-Induced Preterm Delivery: Role of Nitric Oxide (abst – 2010) http://rsx.sagepub.com/content/17/4/391.abstract
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2 (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20471226
Postmortem redistribution of THC in the pig. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20052591
Key ingredient staves off marijuana memory loss (news – 2010) http://www.nature.com/news/2010/101001/full/news.2010.508.html?s=news_rss
Marijuana May Extend Life Expectancy Of Lou Gehrig’s Disease Patients, Study Says (news-2010) http://blog.norml.org/2010/05/19/marijuana-may-extend-life-expectancy-of-lou-gehrig%E2%80%99sdisease-patients-study-says/
New Analysis Says Cannabis Breeders Should Grow for Safety As Well As Potency (news–2010) http://www.popsci.com/science/article/2010-01/lack-balance-not-thc-makes-pot-health-risk
Study: Smoking pot may ease chronic pain (news – 2010) http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/
Science: Cannabidiol enhances the anti-cancer effects of THC on human brain cancer cells (news – 2010) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=313#3
Science: Cannabis effective in the treatment of TOURETTE Syndrome and attention deficit hyperactivity disorder (ADHD) (news–2010) http://www.cannabismed.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=323&search_pattern=tourette#2
A New Use for Medical Marijuana? (news – 2010) http://consults.blogs.nytimes.com/2010/03/31/a-new-use-for-medical-marijuana/
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model (full–2011) http://jpet.aspetjournals.org/content/early/2011/06/14/jpet.111.182717.long
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) http://annonc.oxfordjournals.org/content/early/2011/02/11/annonc.mdq727.full
top
Cannabis with high cannabidiol content is associated with fewer psychotic experiences (full–2011) http://www.schres-journal.com/article/S0920-9964%2811%2900224-6/fulltext
Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242894/pdf/nihms328208.pdf
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Inhibition of monoacylglycerol lipase (MAGL) attenuates NSAID-induced gastric hemorrhages in mice (full–2011) http://jpet.aspetjournals.org/content/early/2011/06/09/jpet.110.175778.long
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388539/
Prospects for cannabinoid therapies in basal ganglia disorders. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131933/
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096803/
The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188916/pdf/bph0164-0655.pdf
Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285765/pdf/213_2011_Article_2479.pdf
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L) (full-2011) http://www.doiserbia.nb.rs/img/doi/0534-0012/2011/0534-00121103449S.pdf
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full-2011) http://annonc.oxfordjournals.org/content/22/9/2086.long
Heterogeneity in the composition of marijuana seized in California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118261/pdf/nihms-271313.pdf
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727221/
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells (full – 2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01461.x/pdf
Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by Δ9-Tetrahydrocannabinol and CP55,940 in the Rat (full–2011) http://jpet.aspetjournals.org/content/340/3/787.full
Cannabinoid Neuroimmune Modulation of SIV Disease. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208744/
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex (full-2011) http://www.sciencedirect.com/science/article/pii/S0006899311001533
top
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645879/
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Combined effects of THC and caffeine on working memory in rats. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423236/
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration (full- 2011) http://www.clinchem.org/content/57/1/66.long
The dual neuroprotective-neurotoxic profile of cannabinoid drugs. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165949/
A combined preclinical therapy of cannabinoids and temozolomide against glioma (full–2011) http://mct.aacrjournals.org/content/10/1/90.full
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140653/
Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA (full-2011) http://www.google.it/patents/WO2010012506A1?cl=en
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory. (full – 2011) http://www.nature.com/npp/index.html
Prolonged excretion half-life of 11-nor-9-carboxy-Δ⁹-THC following cessation in a chronic, heavy marijuana user: implications for liver transplant assessment (1st page–2011) http://www.psychosomaticsjournal.com/article/S0033-3182%2810%2900028-9/abstract
Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21667074
Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/22865360
Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21512341
Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy (abst-2011) http://www.degruyter.com/abstract/j/jbcpp.2011.22.issue-1-2/jbcpp.2011.005/jbcpp.2011.005.xml?rskey=wRYgJd&result=2&q=cannabinoid
Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21645556/abstract/%CE%94_9__THC_and_WIN55212_2_affect_brain_tissue_levels_of_excitatory_amino_acids_in_a_phenotype__compound__dose__and_region_specific_manner_
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabinoids_on_electroencephalogram_power_spectra_in_rats_
top
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shock. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21341278/abstract/Pharmacokinetics_of_a_combination_of_%CE%949_tetrahydro_cannabinol_and_celecoxib_in_a_porcine_model_of_hemorrhagic_shock_
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’ (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21315768
VARIATIONS IN TERPENE PROFILES OF DIFFERENT STRAINS OF CANNABIS SATIVA L (abst–2011) http://www.actahort.org/members/showpdf?booknrarnr=925_15
Biotechnology of Cannabis sativa L (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273535
Ingredient in cannabis restores taste for cancer patients (news – 2011) http://phys.org/news/2011-02-ingredient-cannabis-cancer-patients.html
Marijuana Compound Treats Multiple Health Issues (news – 2011) http://www.foxnews.com/health/2010/03/10/cannabis-deficient/
Another Study Confirms Anti-Cancer Effects of THC and CBD (news – 2011) http://www.examiner.com/medical-marijuana-in-philadelphia/another-study-confirms-anti-cancer-effectsof-thc-and-cbd-1
Marijuana Compound Induces Cell Death In Hard-To-Treat Brain Cancer (news – 2011) http://norml.org/news/2011/01/20/marijuana-compound-induces-cell-death-in-hard-to-treat-brain-cancer
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
Synaptic Targets of Δ9-Tetrahydrocannabinol in the Central Nervous System (full–2012) http://perspectivesinmedicine.cshlp.org/content/early/2012/12/03/cshperspect.a012237.long
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12014/full
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/?tool=pubmed
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02019.x/full
Towards the use of non-psychoactive cannabinoids for prostate cancer. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02121.x/pdf
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Upregulation of Serum IgE Levels in Immunized Mice (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
Cannabidiol in humans-the quest for therapeutic targets (full-2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
top
So what do we call GPR18 now? (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01731.x/full
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01497.x/full
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Rimonabant eliminates responsiveness to workload changes in a time-constrained foodreinforced progressive ratio procedure in rats (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387812/
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3254.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD (full – 2012) http://www.sciencedirect.com/science/article/pii/S0092867412001420
Acute effects of THC on time perception in frequent and infrequent cannabis users (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581701/
Review article: The endocannabinoid system in normal and pathological brain ageing (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Involvement of the endocannabinoid system in reward processing in the human brain (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266503/
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705914/
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial (full–2012) http://jnnp.bmj.com/content/83/11/1125.long
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ(9)-THC in Humans. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358754/
Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258357/
Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189263/
Brain regional differences in CB1 receptor adaptation and regulation of transcription (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772765/
Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697741/
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664416/
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959123/
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full – 2012) http://www.jneurosci.org/content/32/21/7109.long
Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THClike Morris water maze deficits in mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382457/
top
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936256/
Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194211/
NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL – Patent US2012052119 (A1) ― 2012-03-01 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012052119A1&KC=A1&FT=D&ND=3&date=20120301&DB=EPODOC&locale=en_EP
US Patent 8106244 B2 Process for production of delta-9-tetrahydrocannabinol (full–2012) http://www.google.com/patents/US8106244
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF – 2012) http://www.eurekaselect.com/102848/article
Treatment of Tourette syndrome with cannabinoids. (link to PDF – 2012) http://www.hindawi.com/journals/bn/2013/294264/abs/
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Δ(9) -THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22236282
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and postsynaptic serotonergic transmission. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22386778
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716160
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716148
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis. (abst – 2012)
http://www.ncbi.nlm.nih.gov/pubmed/22594565
∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21603976
top
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22885247
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
What place for cannabis extract in MS? (abst – 2012) http://dtb.bmj.com/content/50/12/141.abstract
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetrahydrocannabinol (THC): neuroprotection and ERK signaling (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22821081
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures (abst-2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
Effects of Δ9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study (abst–2012) http://www.mitpressjournals.org/doi/abs/10.1162/jocn_a_00156?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&#.Va6zXvlwtB8
Researchers study neuroprotective properties in cannabis (news – 2012) http://www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-in-cannabis/
Can medical marijuana help rheumatoid arthritis? (news – 2012) http://www.health.com/health/condition-article/0,,20499017,00.html
Cannabinoids May Help Prevent MDMA induced brain damage (news-2012) http://www.examiner.com/article/cannabinoids-may-help-prevent-mdma-induced-brain-damage
Marijuana Compound Found Superior To Drugs For Alzheimer’s (news-2012) http://www.greenmedinfo.com/blog/marijuana-compound-found-superior-drugs-alzheimers
Simple Method: Isolating & Extracting INDIVIDUAL Cannabinoids… from BadKittySmiles (forum post–2012) http://forum.grasscity.com/incredible-edible-herb/1051569-simple-method-isolating-extracting-individualcannabinoids-badkittysmiles.html
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (full – 2013) http://iospress.metapress.com/content/4j61942x88175321/fulltext.html
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674350/
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054795
Modulating the endocannabinoid system in human health and disease: successes and failures (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/febs.12260/pdf
Diuretic effects of cannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
top
Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797438/
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers (full – 2013) http://www.springerplus.com/content/2/1/236
Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703229/
Parsing the players: 2-AG synthesis and degradation in the CNS (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12411/full
Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656362/
Towards a better Cannabis drug (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells (full–2013) http://jpet.aspetjournals.org/content/early/2013/11/20/jpet.113.205120.long
Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-Tetrahydrocannabinol in vivo: Regulation of CCAAT/enhancer binding protein alpha by microRNA-690. (full – 2013) http://www.jbc.org/content/early/2013/11/07/jbc.M113.503037.long
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance (full–2013) http://www.nutritionandmetabolism.com/content/10/1/71
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Induction of the fatty acid 2-hydroxylase (FA2H) gene by ∆9-tetrahydrocannabinol in human breast cancer cells (full–2013) https://www.jstage.jst.go.jp/article/jts/38/2/38_305/_pdf
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587044/
The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinol (full-2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900195-8/fulltext
Influence of Ethanol on the Pharmacokinetic Properties of Δ9-Tetrahydrocannabinol in Oral Fluid (full – 2013) http://jat.oxfordjournals.org/content/37/3/152.full
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629308/
top
The endocannabinoid system, cannabinoids, and pain (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Comparison between self-report of cannabis use and toxicological detection of THC / THCCOOH in blood and THC in oral fluid in drivers in a roadside survey (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1517/full
Amygdala activity contributes to the dissociative effect of cannabis on pain perception (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549497/
Cannabinoid facilitation of fear extinction memory recall in humans (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445738/
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics (full – 2013) http://www.jpsmjournal.com/article/S0885-3924%2812%2900439-3/fulltext
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685885/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full-2013) http://www.jleukbio.org/content/92/5/1093.full
Effect of Cannabinoid Receptor Activation on Spreading Depression. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586901/
Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency (full – 2013) http://www.nutricionhospitalaria.com/pdf/6430.pdf
Pharmacokinetic and Pharmacodynamic Profile of Supratherapeutic Oral Doses of Δ9 -THC in Cannabis Users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691290/
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590996/
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864984/
Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9 tetra-hydrocannabinol (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838683/
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945037/
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health (full – 2013) http://www.hindawi.com/journals/sci/2013/796715/
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Anti-oxidants (link to PDF-2013) http://www.mdpi.com/1420-3049/18/10/12663
Critical appraisal of the potential use of cannabinoids in cancer management (link to PDF-2013) http://www.dovepress.com/critical-appraisal-of-the-potential-use-of-cannabinoids-in-cancer-mana-a14216
Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function (letter–2013) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0032-1316342
top
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23363354
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
Cannabis and Δ(9)-tetrahydrocannabinol (THC) for weight loss? (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23410498
Non-psychotropic analgesic drugs from the endocannabinoid system: “magic bullet” or “multiple-target” strategies? (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23500197
An ultra-low dose of tetrahydrocannabinol provides cardioprotection (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23537701
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/22726074
The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23567453
Tolerance and cross-tolerance among high-efficacy synthetic cannabinoids JWH-018 and JWH-073 and low-efficacy phytocannabinoid 9-THC (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.1?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva) (abst – 2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1093.20?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Effects of anandamide and other CB1 ligands on cognitive function (abst – 2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.10?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Conditioned taste aversion elicited by synthetic cannabinoid JWH-018 in mice is attenuated by pretreatment with phytocannabinoid {Delta}9-THC (abst – 2013) http://www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/660.4?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/1123.1?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Do cannabinoids exhibit a tyramine-like effect? (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23900610
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol? (abst–2013) http://jop.sagepub.com/content/26/10/1307.abstract
Chronic Cannabis Abuse, Delta-9-tetrahydrocannabinol and Thyroid Function (abst–2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336455
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23707295
Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773072
Intraperitoneal injection of -9-tetrahydrocannabinol induces local MDSCs with potent immunosuppressive properties (abst-2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/208.5?sid=c3422dd2 -7ad0-42e4-a862-845dc670f7cf
Palmitoylethanolamide: From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23896215
top
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23103902
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23020923
Exercise increases plasma THC concentrations in regular cannabis users (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24018317
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24030360
Diuretic effects of cannabinoid agonists in mice. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0014299913007176
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst – 2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24157976
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24160757
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23095052
Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23845579
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1111/jgh.12346/abstract
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst – 2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1002/cpdd.36/abstract
Marijuana’s dose-dependent effects in daily marijuana smokers (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23937597
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB₁ (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23494106
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1336533
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE (abst–2013) http://en.journals.sid.ir/ViewPaper.aspx?ID=351874
Study: THC Increases Brain Activity In Response To Positive Stimuli (news-2013) http://blog.norml.org/2013/08/27/study-thc-increases-brain-activity-in-response-to-positive-stimuli/
top
Science/Human: THC reduces sleep apnoea in small clinical study (news-2013) http://www.cannabismed.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=392&search_pattern=2013#2
New Study Finds THC Kills Stomach Cancer Cells (news-2013) http://thejointblog.com/new-study-finds-thc-may-treat-stomach-cancer/
Study: cannabis compound might have use as an HIV drug (news-2013) http://www.wired.co.uk/news/archive/2013-05/1/cannabis-hiv-drug
Low Doses of THC (Cannabis) Can Halt Brain Damage, Study Suggests (news-2013) http://www.sciencedaily.com/releases/2013/05/130530132531.htm
THC Can Prevent Brain Damage – Study (news-2013) http://www.science20.com/news_articles/thc_can_prevent_brain_damage_study-113512
Sending multiple sclerosis up in smoke (news-2013) http://www.eurekalert.org/pub_releases/2013-10/afot-sms100713.php
Preventing marijuana-induced memory problems with over-the-counter painkillers (news-2013) http://medicalxpress.com/news/2013-11-marijuana-induced-memory-problems-over-the-counterpainkillers.html
Scientists Have Found A Way To Make Marijuana Un-Fun (news–2013) http://www.popsci.com/article/science/scientists-have-found-way-make-marijuana-un-fun
In Mice Anti-Inflammatories Ameliorate Medical Marijuana’s Memory Mishaps (news-2013) http://news.yahoo.com/mice-anti-inflammatories-ameliorate-medical-marijuanas-memory-mishaps-165808519.html
South Carolina researchers find THC in pot could turn microRNA on or off (news-2013) http://medcitynews.com/2013/11/south-carolina-researchers-find-thc-pot-turn-microrna/
Poor Sleep Quality Makes It Harder To Quit Marijuana – Here’s Why (news-2013) http://www.leafscience.com/2013/09/27/poor-sleep-quality-makes-harder-quit-marijuana-why/
Neurotransmitters Studied as Way to Enhance PTSD Treatment (news-2013) http://psychnews.psychiatryonline.org/doi/full/10.1176%2Fappi.pn.2013.7b9
New Study: THC May Treat Inflammatory Diseases and Cancer By Altering Genes (news–2013) http://thejointblog.com/new-study-thc-may-treat-inflammatory-diseases-cancer-altering-genes/
Not That High (news-2013) http://www.slate.com/articles/health_and_science/science/2013/03/marijuana_potency_returning_smokers_want_mellower_pot_strains.html
Chemicals in marijuana ‘protect nervous system’ against MS (news – 2013) http://www.medicalnewstoday.com/articles/267161.php
High levels of THC in Australian cannabis (news – 2013) http://medicalxpress.com/news/2013-07-high-thc-australian-cannabis.html
Marijuana’s Memory Paradox (news-forum repost–2013) http://ehealthforum.com/health/interesting-t164409.html
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full – 2014) http://www.karger.com/Article/FullText/357742
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke (full–2014) http://www.researchgate.net/publication/236185970_Hair_analysis_for_THCAA_THC_and_CBN_after_passive_in_vivo_exposure_to_marijuana_smoke
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
top
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (full-2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia (full–2014) http://schizophreniabulletin.oxfordjournals.org/content/early/2014/07/01/schbul.sbu098.long
Vascular targets for cannabinoids: animal and human studies (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http://www.neurology.org/content/82/17/1556.long
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective. (full– 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full–2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representation=PDF
Cannabis and Cannabinoids (PDQ®)- National Cancer Institute (full-2014) http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page4
Impact of efficacy at the mu opioid receptor on antinociceptive effects of combinations of mu opioid receptor agonists and cannabinoid receptor agonists (full–2014) http://jpet.aspetjournals.org/content/early/2014/09/05/jpet.114.216648.long
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131522/
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/add.12508/full
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults. (full – 2014) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472%2814%2900164-0/pdf
Evaluation of sex differences in cannabinoid dependence. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971653/
Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1692/full
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat. (full – 2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/’Spice’ constituent JWH-018 in mice (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157458/
Modulation of Gut-Specific Mechanisms by Chronic Δ9-THC Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046212/
top
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988329/
The case for medical marijuana in epilepsy. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243853/
Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251811/
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089388/
Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection. (full – 2014)
http://www.ncbi.nlm.nih.gov/pubmed/24562630
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945413/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users. (full– 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
A protocol for the delivery of cannabidiol (CBD) and combined CBD and [increment]9-tetrahydrocannabinol (THC) by vaporisation. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (full – 2014) http://www.karger.com/Article/Pdf/367615
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12746/full
Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081916/
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (full–2014) http://jvi.asm.org/content/89/2/1168.long
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233
Medical Cannabis Research, What the Science Says (article – 2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosisrelated spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Profiling the subjective effects of Δ9 -tetrahydrocannabinol using visual analogue scales (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24496889
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
Acute administration of THC impairs spatial but not associative memory function in zebrafish. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24639045
top
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24676249
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24696079
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24699310
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24719095
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy volunteers. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24802974
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853387
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24858366
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24857780
Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel Biosignaling Systems. (abst – 2014) http://pubs.acs.org/doi/abs/10.1021/cn5000875
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24894801
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24910342
Sex Differences in Δ9-Tetrahydrocannabinol Metabolism and In Vivo Pharmacology Following Acute and Repeated Dosing in Adolescent Rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24909619
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part I: Development and Validation of a Pulmonary Cannabinoid Route of Exposure for Experimental Pharmacology Studies in Rodents. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24973534
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24956154
top
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24976505
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (abst – 2014) http://iospress.metapress.com/content/8421pvx80144t354/?p=ff122a13e6cf4bf78324e26d253bd883&pi=8
Cannabinoids for epilepsy: is marijuana an effective treatment for epilepsy? (abst–2014) http://iospress.metapress.com/content/p50752072175783q/?p=00368d67a25c414b9e1ecc38b534bdfc&pi=14
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25035121
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch2/summary
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington’s disease may depend on their functional selectivity (abst-2014) http://www.fasebj.org/content/28/1_Supplement/846.6.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Pharmacokinetics and relative bioavailability of THC and THC-solid dispersion orally to mice at single dose (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24956859
The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats (abst–2014) http://www.fasebj.org/content/28/1_Supplement/838.6.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINEACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1 (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25069049
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable MeteredDose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25118789
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25131716
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25092427
Multifractal analysis of information processing in hippocampal neural ensembles during working memory under Δ9-tetrahydrocannabinol administration (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25086297
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9 -THC (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240
Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25173986
Cannabinoid-induced changes in respiration of brain mitochondria. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25195527
top
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25220020
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25083569
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Effect of Marijuana Use on Outcomes in Traumatic Brain Injury (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25264643
Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified PLGA nanoplatforms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25262411
Relationship between cannabinoids content and composition of fatty acids in hempseed oils (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25306338
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25282526
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25316574
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
Cannabinoids and schizophrenia: therapeutic prospects. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25398831
Comparative effects of pulmonary and parenteral Δ9-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25395060
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9-tetrahydrocannabinol in Sprague-Dawley rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25425111
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
Cannabinoids in experimental stroke: a systematic review and meta-analysis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25492113
Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25498928
Interaction Between the Endocannabinoid and Serotonergic System in the Exhibition of Head Twitch Response in Four Mouse Strains. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25516122
Potential applications of marijuana and cannabinoids in medicine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
top
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25037227
Stereodivergent Total Synthesis of Δ9-Tetrahydrocannabinols (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/ange.201408380/abstract
Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24879495
Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24424782
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
Who Discovered THC? Setting the Record Straight (news-2014) http://cannabisdigest.ca/discovered-thc-setting-record-straight/
Active ingredient in pot sets off a feedback that reduces intoxication (news-2014) http://arstechnica.com/science/2014/01/active-ingredient-in-pot-sets-off-a-feedback-that-reducesintoxication/
Cannabinoid Breakdown (news–2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
Cannabis Chemistry 101 (news–2014) http://www.greencultured.co/cannabis-chemistry-101/
Retired Flint couple sees the light on medical marijuana (news–2014) http://www.mlive.com/news/flint/index.ssf/2014/04/retired_flint_couple_sees_the.html
Cannabis extract can have dramatic effect on brain cancer, says new research (news–2014) http://medicalxpress.com/news/2014-11-cannabis-effect-brain-cancer.html
Cannabis Science: Finding The Optimal Therapeutic Ratio Of THC And CBD (news–2014) http://www.medicaljane.com/2014/05/29/finding-the-optimal-therapeutic-ratio-ofthc-and-cbd/#
Biohackers Are Engineering Yeast to Make THC (news-2014) http://motherboard.vice.com/read/biohackers-are-engineering-yeast-to-make-thc
How Cannabis Might Keep Coronary Stents Open Longer (news–2014) http://www.cbds.com/medicine/how-cannabis-might-keep-coronary-stents-open-longer/
Study uncovers marijuana’s potential to treat autoimmune diseases (news–2014) http://www.news-medical.net/news/20140603/Study-uncovers-marijuanas-potential-to-treat-autoimmunediseases.aspx
THC, CBD And More: The Entourage Effect Of Whole-Plant Cannabis Medicine (news–2014) http://www.medicaljane.com/2014/05/14/thc-cbd-and-more-the-entourage-effect-of-whole-plant-cannabismedicine/
The Miracle Worker (news – 2014) http://ireadculture.com/article-3695-the-father-of-modern-medical-cannabis-research-returns-with-an-allbut-impossible-new-study-of-cannabis-on-humans.html
How marijuana shrinks cancerous tumours (news–2014) https://en-maktoob.news.yahoo.com/marijuana-shrinks-cancerous-tumours-122611456.html
Marijuana compound may offer treatment for Alzheimer’s disease (news–2014) http://medicalxpress.com/news/2014-08-marijuana-compound-treatment-alzheimer-disease.html
top
Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients (news-2014) http://blog.norml.org/2014/08/18/study-cannabis-inhaler-delivers-effective-relief-to-neuropathy-patients/
Low or No THC, High CBD Medical Marijuana Bills: Leaving Most Patients Behind (news–2014) https://www.mpp.org/low-or-no-thc-high-cbd-medical-marijuana-bills/
Calculating THC dosage for weed-infused recipes (news–2014) http://www.thecannabist.co/2014/07/07/marijuana-recipes-calculating-thc-dosage-cannabutter-canna-oilsmarijuana-infused/15457/
Marijuana Drastically Shrinks Aggressive Form Of Brain Cancer, New Study Finds (news–2014) http://www.huffingtonpost.com/2014/11/18/marijuana-brain-cancer_n_6181060.html
Marijuana compound may halt Alzheimer’s disease – study (news–2014) http://rt.com/news/183948-marijuana-compound-stop-alzheimer/
Why Marijuana Needs Chemical Quality Control Testing (news–2014) http://www.popsci.com/article/science/why-marijuana-needs-chemical-quality-control-testing
DR ALLAN FRANKEL’S EARLY VERSION INITIAL DOSAGE AND ADMINISTRATION GUIDE (news–2014) http://www.greenbridgemed.com/dr-allan-frankels-early-version-initial-dosage-and-administration-guide/
MEDICAL MARIJUANA : Out of the Shadows (news–2014) http://cannabisclinicians.org/wp-content/uploads/2014/04/SCMA-Spring-2014-Kerr.pdf
Alzheimer’s Caused By Loss of Cannabinoids, Study Shows (news–2014) http://www.leafscience.com/2014/06/23/alzheimers-caused-loss-cannabinoids-studyshows/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis
Cannabis May Protect The Aging Brain, Say Experts (news–2014) http://www.leafscience.com/2014/05/07/cannabis-may-protect-aging-brain-say-experts/
New Research Shows How Marijuana Compound Can Reduce Tumor Growth In Cancer Patients (news–2014) http://www.huffingtonpost.com/2014/07/16/marijuana-tumors_n_5588639.html
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full–2015)
http://www.hindawi.com/journals/mi/2015/362126/
Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ9-tetrahydrocannabinol (THC) (full–2015) http://www.sciencedirect.com/science/article/pii/S037663571500042X
Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (full–2015) http://www.jbc.org/content/early/2015/02/09/jbc.M114.618447.long
Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050269
Sex-dependent vulnerability to Cannabis abuse in adolescence (full – 2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015) http://www.hindawi.com/journals/mi/2015/349176/
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function (full–2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
top
The cannabis conundrum: Thinking outside the THC box (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jcph.511/full
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death (full–2015) http://www.nature.com/jid/journal/v135/n6/pdf/jid201545a.pdf
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Effects of Cannabinoids on T-cell Function and Resistance to Infection (full–2015) http://tinyurl.com/pt667v9
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/pe7eb73
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain (full–2015) http://jpet.aspetjournals.org/content/early/2015/06/22/jpet.115.224428.long
Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats (full – 2015) http://journal.frontiersin.org/article/10.3389/fphar.2015.00133/full
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury (full–2015) http://www.karger.com/Article/Pdf/430165
Current Status and Future of Cannabis Research (full–2015) http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Potency 101 (printable card set–2015) http://greenstyleconsulting.com/potency-101/
Cannabinoid and Terpene Info (chart–2015) http://skunkpharmresearch.com/cannabinoid-info/
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25492688
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25425209
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
A Synthetic Cannabinoid MAM-2201 Potently Suppresses Synaptic Transmission via Activation of Presynaptic CB1 Receptors and Reduces Synaptically-Evoked Intracellular Ca2+ Transients in Cerebellar Purkinje Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25747605
Evaluation of an On-site Drug-testing Device for the Detection of Synthetic Cannabinoids in Illegal Herbal Products (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25759062
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25772338
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25537576
The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25779032
Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788107
top
Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25725933
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25703248
Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ9-tetrahydrocannabinol (THC) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25637881
Simultaneous inhibition of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) shares discriminative stimulus effects with ∆9-THC in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25711338
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
Cannabidiol, a Major Non-Psychotrophic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801536
Distribution of ∆9 -Tetrahydrocannabinol and 11-Nor-9-Carboxy-∆9 -Tetrahydrocannabinol Acid in Postmortem Biological Fluids and Tissues From Pilots
Fatally Injured in Aviation Accidents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25800046
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25799920
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801289
Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25698527
Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25820672
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25832823
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843054
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25863271
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25900076
Differential role of cannabinoids in the pathogenesis of skin cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921771
The endocannabinoid system and associative learning and memory in zebrafish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25956869
JWH-018 impairs sensorimotor functions in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25987201
top
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26034207
Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Δ9-tetrahydrocannabinol in rat plasma (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048666
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26061356
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092091
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain. (abst – 2015) Selective Reduction of THC’s Unwanted Effects through Serotonin Receptor Inhibition (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26158526
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179998
Strain and sex differences in puberty onset and the effects of THC administration on weight gain and brain volumes (abst–2015)
http://www.sciencedirect.com/science/article/pii/S0306452215006387
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26218440
Potency trends of Δ9 -THC, cannabidiol and cannabinol in cannabis in the Netherlands:2005-2015 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26234170
The impact of gonadal hormones on cannabinoid dependence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237318
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127
When Weed Is The Cure: A Doctor’s Case for Medical Marijuana (interview–2015) http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana?utm_medium=RSS&utm_campaign=authorinterviews
How Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
Marijuana Is Effective In Treating Depression – Latest Study (news–2015) http://au.ibtimes.com/marijuana-effective-treating-depression-latest-study-1419071
Cannabis: World-renowned researchers discuss a new frontier in therapeutics (news–2015) http://medicalxpress.com/news/2015-02-cannabis-world-renowned-discuss-frontier-therapeutics.html
top
The Science Behind Sanjay Gupta’s WEED 3 (news–2015) http://blog.sfgate.com/smellthetruth/2015/04/21/the-science-behind-sanjay-guptas-weed-3/
An alternative to medical marijuana for pain? (news–2015) http://medicalxpress.com/news/2015-03-alternative-medical-marijuana-pain.html
New Study Shows Marijuana May Help Fight Cancer (news–2015) http://finance.yahoo.com/news/study-shows-marijuana-may-help-153150501.html;_ylt=AwrXgiKcSoRVdnMAJ67QtDMD;_ylu=X3oDMTByM3V1YTVuBGNvbG8DZ3ExBHBvcwMzBHZ0aWQDBHNlYwNzcg–
UEA scientists separate medical benefits of cannabis from unwanted side effects (news–2015) http://www.alphagalileo.org/ViewItem.aspx?ItemId=154355&CultureCode=en
Medical Marijuana Is Often Less Potent Than Advertised (news–2015) http://www.npr.org/sections/health-shots/2015/06/23/416791647/medical-marijuana-is-often-less-potentthan-advertised
At 82, he’s the world’s most eminent pot scientist (news–2015) http://www.benningtonbanner.com/ci_23945794/israels-cannabis-scientist?source=rss_viewed
The Endocannabinoid System for Beginners (news–2015) http://cannabisnowmagazine.com/cannabis/medical/the-endocannabinoid-system-for-beginners


THC ACID/THCA
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full – 2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Cannabis as a Unique Functional Food (full – 2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-svyr5/cannabis_as_a_unique_functional_food.pdf
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Immunochemical approach using monoclonal antibody against Δ(9)-tetrahydrocannabinolic acid (THCA) to discern cannabis plants and to investigate new drug candidates. (link to PDF – 2011) http://www.eurekaselect.com/94339/article
A real-time PCR assay for the relative quantification of the tetrahydrocannabinolic acid (THCA) synthase gene in herbal Cannabis samples (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22093702
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
Structure and Function of Δ1-Tetrahydrocannabinolic Acid (THCA) Synthase, the EnzymeControlling the Psychoactivity of Cannabis sativa. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22766313
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
top
In planta imaging of Δ9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy (full-2013) http://os.tnw.utwente.nl/publications/pdf/237.pdf
Extraction of high quality DNA from seized moroccan cannabis resin (hashish) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790795/
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792001/
Analysis of THCA synthase gene expression in cannabis: A preliminary study by realtime quantitative PCR. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23890639
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
Affinity comparison of different THCA synthase to CBGA using modeling computational approaches (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916817/
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke (full–2014) http://www.researchgate.net/publication/236185970_Hair_analysis_for_THCAA_THC_and_CBN_after_passive_in_vivo_exposure_to_marijuana_smoke
Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1692/full
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF–2014) http://www.mdpi.com/1420-3049/19/11/18781
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
A PCR marker Linked to a THCA synthase Polymorphism is a Reliable Tool to Discriminate Potentially THC-Rich Plants of Cannabis sativa L (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/1556-4029.12448/abstract
Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25173986
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014)
http://www.ncbi.nlm.nih.gov/pubmed/25311884
Scientists Make Breakthrough In Genetic Screening For Cannabis (news – 2014) http://www.leafscience.com/2014/03/06/scientists-make-breakthrough-genetic-screening-cannabis/
Potency 101 (printable card set – 2015) (good info!) http://greenstyleconsulting.com/potency-101/
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Production of Δ9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing Δ9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25994576
Δ9-Tetrahydrocannabinolicacid synthase production in Pichia pastoris enables chemical synthesis of cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26197418
top
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127


TETRAHYDROCANNABIORCOL
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/22109525


THCV/TETRAHYDROCANNABIVARIN/GWP-42004
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol (full-2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815025/?tool=pubmed
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931567/?tool=pubmed
Delta-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. (full – 2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2010.02523.x/full
A randomised, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GW42003 : GW42004 plus GW42003 and GW42004 alone in the treatment of dyslipidaemia in subjects with Type 2 diabetes (research summary – 2010) http://www.hra.nhs.uk/news/research-summaries/gwmd1092-gw42003gw42004-together-plus-alone-intype-ii-diabetes/#sthash.FT2P6YcB.dpuf
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst – 2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
Anticonvulsant effects of GWP42006 in vitro and in vivo in rat (abst – 2010) http://www.physoc.org/proceedings/abstract/Proc%20Physiol%20Soc%2019C117
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9) -THCV in animal models of Parkinson’s disease (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165958/pdf/bph0163-1495.pdf
CB(1) -independent mechanisms of Δ(9) -THCV, AM251 and SR141716 (rimonabant) (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.2011.01284.x/full
US Patent Application 20110082195 – NEW USE FOR CANNABINOIDS (full – 2011) http://www.faqs.org/patents/app/20110082195
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessivecompulsive behaviour (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21796370
New research provides hope for those with epilepsy (news – 2011) http://medicalxpress.com/news/2011-04-epilepsy.html
Cannabis could help treat epilepsy # 1 (news – 2011) http://www.newkerala.com/news/world/fullnews-186693.html
top
Cannabis could be used to treat epilepsy #2 (news – 2011) http://www.telegraph.co.uk/science/science-news/8440303/Cannabis-could-be-used-to-treat-epilepsy.html
Pot Compound Exerts Anticonvulsant Effects In Animal Models Of Epilepsy (news-2011) http://www.norml.org/index.cfm?Group_ID=8458
Δ(8) -Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423240/
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349875/
Δ(8) -Tetrahydrocannabivarin protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress and inflammatory response involving CB(2) receptors (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01410.x/full
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy: Patent Application 20120004251 (full – 2012)
http://www.freshpatents.com/-dt20120105ptan20120004251.php
THCVA-A – a new additional marker for illegal cannabis consumption (abst – 2012) http://www.fsijournal.org/article/S0379-0738%2811%2900115-0/abstract
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart–2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Phytocannabinoids as novel therapeutic agents in CNS disorders (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21924288
How marijuana could help cure obesity-related diseases (news – 2012) http://news.yahoo.com/marijuana-could-help-cure-obesity-related-diseases-175900182.html
Those Pungent Smells Oozing Out of Marijuana Buds Are Actually Giving You Clues About What Their Effects Will Be Like (news – 2012) http://www.alternet.org/drugs/those-pungent-smells-oozing-out-marijuana-buds-are-actually-giving-youclues-about-what-their
Cannabis can help treat obesity (news – 2012) http://in.news.yahoo.com/cannabis-help-treat-obesity-121931025.html
5 Marijuana Compounds That Could Help Combat Cancer, Alzheimers, Parkinsons (If Only They Were Legal) (news – 2012) http://www.alternet.org/drugs/5-marijuana-compounds-could-help-combat-cancer-alzheimers-parkinsonsif-only-they-were-legal
The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671751/
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9 -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792004/
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control) (full – 2013) http://www.freepatentsonline.com/y2013/0245110.html
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1336533
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23103902
Tetrahydrocannabivarin (THCV): A Cannabinoid Fighting Obesity (news – 2013) http://www.medicaljane.com/2013/08/27/tetrahydrocannabivarin-thcv-a-cannabinoid-fighting-obesity/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
top
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. (full – 2014)
http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers. (full – 2014) http://ijnp.oxfordjournals.org/content/18/6/pyu094.long
Cannabinoid Breakdown (news – 2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25363799
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25595882
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26197538
Cannabinoid and Terpene Info (chart – 2015) http://skunkpharmresearch.com/cannabinoid-info/
Cannabis: World-renowned researchers discuss a new frontier in therapeutics (news–2015) http://medicalxpress.com/news/2015-02-cannabis-world-renowned-discuss-frontier-therapeutics.html


TRANS-CARYOPHYLLENE
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (full–2013) http://ajp.amjpathol.org/article/S0002-9440%2812%2900890-5/fulltext
Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23747418
The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24055516
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news – 2013) http://www.sciencedaily.com/releases/2013/02/130221141140.htm
Cannabinoid Trans-Caryophyllene Protects Brain Cells From Ischemia (news–2013) http://www.medicalnewstoday.com/articles/256799.php
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24486541
The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice (abst–2014) http://www.sciencedirect.com/science/article/pii/S0944711313003097
Neuroprotective effects of trans-caryophyllene against kainic Acid induced seizure activity and oxidative stress in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25417010
top


Advertisements